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ABSTRACT 
There is a great need to find treatments that are more effective and less aggressive 
against serious diseases, such as multidrug-resistant bacterial infections and cancer. 
Natural compounds are being increasingly used in biotechnological applications and a 
large fraction of these substances is channeled to the pharmaceutical industry due to their 
important bioactive properties. The discovery of new bioactive compounds with novel 
mechanisms of action constitutes a promising solution for the designing of new therapeutic 
solutions. 
Actinobacteria are a group of Gram-positive and filamentous bacteria well known for their 
unmatched capacity to produce a vast range of bioactive compounds with high industrial 
and pharmaceutical importance.  In recent years a great interest has emerged in the 
research of marine actinobacteria for the discovery of new bioactive molecules, mainly as 
a consequence of the overexploitation of this group of bacteria in terrestrial environments. 
The Portuguese coast is scantly explored in terms of actinobacterial diversity and of their 
bioactive potential. Such unexplored environments offer a great opportunity to obtain new 
marine actinobacteria, also increasing the chances of finding new natural products with 
bioactivity. 
The present master's thesis aimed at the isolation of actinobacteria from marine 
environments of the Portuguese northern coast and investigation of their potential to 
produce bioactive compounds with antimicrobial or anticancer activities.  
The first study of this thesis consisted in the investigation of actinobacteria associated with 
a sediment sample collected from the intertidal zone of a beach located on Parque Natural 
do Litoral Norte, through a cultivation-dependent approach, and in the screening of the 
bioactive potential of the obtained actinobacterial isolates. To improve the efficiency of 
actinobacteria isolation, three different treatment methods and three selective culture 
media were used. A total of 117 isolates were obtained, of which 52 strains were assigned 
to the phylum Actinobacteria. Seven different genera of actinobacteria could be identified, 
with the largest fraction of the isolates belonging to the genus Micromonospora. Some 
non-actinobacterial isolates were also obtained, belonging to the phyla Firmicutes, 
Proteobacteria and Bacteroidetes. Crude extracts of all actinobacterial isolates were 
screened for antimicrobial and anticancer activities. Some strains identified as 
Streptomyces and Micromonospora species showed promising antimicrobial and 
anticancer activities. The results obtained demonstrate the importance of bioprospecting 
other coastal marine sediments in Portugal. 
The second study presented in this thesis focused on the isolation and identification of rare 
actinobacteria from the marine sponge Hymeniacidon perlevis, collected on the intertidal 
zone of a beach on the northern Portuguese coast. To increase the isolation success of 
rare actinobacteria, three selective pretreatments and culture media were employed. In 
total, 188 strains were isolated but only 18 were possible to be identified to date. 
Identification results showed that the experimental approach used allowed the isolation of 
rare genera of actinobacteria such as Nocardia, Nocardiopsis, Brevibacterium, Gordonia 
and Tsukamurella, which are very promising concerning the production of bioactive 
compounds. The results so far obtained also suggest that the studied sponge appears to 
be rich in actinobacteria. 
In the future, it will be necessary to better investigate the antimicrobial and anticancer 
activities of the crude extracts obtained in the first study and find if these extracts may 
contain new bioactive molecules. It will be also important to identify the remaining isolates 
derived from the second study and screen for their ability to produce bioactive compounds  
In general, the results obtained in this thesis are a good contribution to the scarce 
information available in the literature on actinobacteria associated with marine sediments 
and sponges of the northern coast of the country, as well on their bioactive potential.  
 
 
 
 
 
 
 
 
 
 
RESUMO  
Existe uma grande necessidade de encontrar tratamentos mais eficazes e menos 
agressivos contra doenças graves, como infeções provocadas por bactérias resistentes a 
múltiplos fármacos e cancro. Os compostos naturais são cada vez mais utilizados em 
aplicações biotecnológicas, sendo uma grande fração dessas substâncias canalizada 
para a indústria farmacêutica devido às suas importantes propriedades bioativas. A 
descoberta de novos compostos bioativos com novos mecanismos de ação constitui uma 
solução promissora para a conceção de novas soluções terapêuticas. 
As actinobactérias são um grupo de bactérias Gram-positivas e filamentosas bem 
conhecidas pela sua capacidade inigualável de produção de uma vasta gama de 
compostos bioativos, com elevado interesse industrial e farmacêutico. Nos últimos anos, 
foi despoletado um grande interesse pela investigação de actinobactérias marinhas para a 
pesquisa de novas moléculas bioativas, principalmente devido à sobre exploração deste 
grupo de bactérias em ambientes terrestres. A costa portuguesa encontra-se muito pouco 
explorada em termos da sua diversidade actinobacteriana e do seu potencial para 
produzir compostos bioativos. Tais ambientes inexplorados oferecem uma ótima 
oportunidade para obter novas actinobactérias marinhas, aumentando também as 
chances de se encontrar novos produtos naturais com bioatividade. 
A presente tese de mestrado tem como objetivo o isolamento de actinobactérias de 
ambientes marinhos da costa norte Portuguesa e investigação do seu potencial para 
produzir compostos bioativos com atividades antimicrobianas ou anticancerígenas. 
O primeiro estudo desta tese consistiu na investigação de actinobactérias associadas a 
uma amostra de sedimento recolhida na zona intertidal de uma praia localizada no Parque 
Natural do Litoral Norte, através de uma abordagem dependente de cultivo, e no estudo 
do potencial bioativo dos isolados de actinobactérias obtidos. De forma a aumentar a 
eficácia do isolamento de actinobactérias, foram utilizados três métodos de tratamento 
diferentes e três meios de cultura seletivos. No total, 117 isolados foram obtidos, dos 
quais 52 estirpes se verificaram pertencerem ao filo Actinobacteria. Foram identificados 
sete géneros diferentes de actinobactérias, com a maior fração dos isolados pertencendo 
ao género Micromonospora. Foram também obtidos alguns isolados não-
actinobacterianos, pertencentes aos filos Firmicutes, Proteobacteria e Bacteroidetes. Os 
extratos brutos de todos os isolados actinobacterianos foram analisados quanto às suas 
atividades antimicrobianas e anticancerígenas. Algumas estirpes identificadas como 
espécies de Streptomyces e Micromonospora mostraram atividades antimicrobianas e 
anticancerígenas promissoras. Os resultados obtidos demonstram a importância da 
bioprospecção de outros sedimentos marinhos costeiros em Portugal. 
O segundo estudo apresentado nesta tese focou-se no isolamento e identificação de 
actinobactérias raras da esponja marinha Hymeniacidon perlevis, recolhida na zona 
intertidal de uma praia na costa norte do país. Para aumentar o sucesso de isolamento de 
actinobactérias raras, foram utilizados três pré-tratamentos e meios de cultura seletivos. 
No total, 188 estirpes foram isoladas, mas apenas 18 foram possíveis de ser identificadas 
até a data. Os resultados de identificação mostraram que a abordagem experimental 
utilizada permitiu o isolamento de géneros raros de actinobactérias como Nocardia, 
Nocardiopsis, Brevibacterium, Gordonia e Tsukamurella, os quais são muito promissores 
quanto à produção de compostos bioativos. Os resultados obtidos até agora também 
sugerem que a esponja estudada parece ser rica em actinobactérias. 
No futuro, será necessário investigar melhor as atividades antimicrobianas e 
anticancerígenas dos extratos brutos obtidos no primeiro estudo e verificar se esses 
extratos podem conter novas moléculas bioativas. Também será importante identificar os 
restantes isolados derivados do segundo estudo e estudar a sua capacidade de produzir 
compostos bioativos. 
Em geral, os resultados obtidos nesta tese são um bom contributo para a escassa 
informação disponível na literatura sobre actinobactérias associadas a sedimentos 
marinhos e esponjas da costa norte do país, bem como sobre o seu potencial bioativo.  
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 Introduction 
The search for new drugs to combat diseases for which treatments are inexistent or no 
longer effective is an urgent topic. Cancer and multidrug-resistant bacterial infections are 
at the top of diseases for which new therapies are needed. As health problems represent a 
constant threat to humanity, it is necessary to continuously seek for new solutions, one of 
which is the discovery of new bioactive compounds (Duncan et al., 2015). 
Actinobacteria are an extremely important source of diverse bioactive compounds with 
industrial and pharmaceutical interest (Claverias et al., 2015; Stach et al., 2003). For more 
than 50 years, actinobacteria have been studied due to their unique ability to produce 
bioactive metabolites relevant for human health, such as: antibiotics (e.g., amphotericin B, 
erythromycin), antifungal agents (e.g., chandrananimycin A), antiparasitic agents (e.g., 
avermectins), antiviral agents (e.g., benzatatin C), anticancer agents (e.g., daunorubicin, 
bleomycin, mitomycin), immunosuppressive agents (e.g., papamycin) and anti-
inflammatory agents (e.g., cyclomarin A, salinamides A and B). They are also important 
producers of enzymes (e.g., amylase, protease, cellulase, halogenases), enzyme 
inhibitors (e.g., pyrizinostatin, pyrostatin), fungicides (e.g., nystatin), pigments (e.g., dark 
pigments, melanin or melanocytes), herbicides (e.g., herbicide A and B, anisomycin) and 
plant and animal growth promoting substances (Donadio et al., 2002; Manivasagan et al., 
2014; Pimentel-Elardo et al., 2010; Subramani & Aalbersberg, 2012). 
Production of bioactive compounds has been mostly explored in terrestrial actinobacteria, 
perhaps due to the easier access to samples, however the constant search of terrestrial 
environments has often led to the re-isolation of known phylotypes, making it difficult to 
find novel species and, consequently, new bioactive compounds (Zotchev, 2012). 
Compared to terrestrial environments, oceans support a much greater biodiversity and  
cover more than 70% of the terrestrial surface (Donia & Hamann, 2003). Due to the 
profoundly different characteristics of the terrestrial environments compared with marine 
ecosystems, it is reasonable to expect that oceans harbour distinct marine actinobacteria 
with the capacity to produce novel bioactive compounds (Manivasagan et al., 2013). 
Marine actinobacteria are widely distributed in the oceans and can be found in fish, 
sponges, seaweed, mollusks, seawater, sediments, etc. In the recent years, these 
microorganisms have incited the interest of researchers, not only for their taxonomic 
diversity and ecological importance but also for the possibility of biosynthesis of new 
natural products (Dharmaraj, 2010). However, despite a more intense research on marine 
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actinobacteria and isolation efforts, the oceans still remain underexplored ecosystems with 
respect to the diversity of these microorganisms (Stach & Bull, 2005) and of their 
metabolites produced (Manivasagan et al., 2014). 
 Phylum Actinobacteria 
The phylum Actinobacteria constitutes one of the largest taxonomic units, either in number 
and diversity, within the main known lineages that integrate the domain Bacteria (Ventura 
et al., 2007). It covers a vast group of Gram-positive bacteria with diverse morphological 
and physiological characteristics, usually sharing a high genomic guanine+citosine 
content, which can vary from 50% to more than 70% (Barkal et al., 2016; Ventura et al., 
2007). 
The taxonomy of this phylum has been recently reviewed and, according to this update, 
the phylum now includes the classes Actinobacteria, Acidimicrobidiia, Coriobacteriia, 
Nitriliruptoria, Rubrobacteria, and Thermoleophilia (Ludwig et al., 2015). The class 
Actinobacteria integrates most of the taxonomic units responsible for the production of 
bioactive compounds, commonly known as actinomycetes, and it comprehends 15 orders: 
Actinomycetales, Actinopolysporales, Bifidobacteriales, Catenulisporales, 
Corynebacteriales, Frankiales, Glycomycetales, Jiangellales, Kineosporiales, 
Micrococcales, Micromonosporales, Propionibacteriales, Pseudonocardiales 
Streptomycetales and Streptosporangiales. In this thesis, the term actinobacteria will be 
used as synonymous of the class Actinobacteria. 
The diversity of species of actinobacteria includes pathogens (e.g., Corynebacterim, 
Mycobacterium, Nocardia, Propionibacterium and Thropherma spp.), soil or aquatic 
inhabitants (e.g., Micromonospora,  Rhodococcus, Salinispora and Streptomyces spp.), 
plant pathogens (e.g., Leifsonia spp.), nitrogen-fixing plant symbionts (Frankia spp.) and 
inhabitants of the gastrointestinal tract (e.g., Bifidobacterium spp.) (Barka et al., 2016; 
Ventura et al., 2007). Actinobacteria present a great diversity of morphologies, such as 
coccoid (Micrococcus spp.) or rod-coccoid (e.g., Arthrobacter spp.), and also contemplate 
species where hyphae fragmentation occurs (e.g., Nocardia spp.) or that are differentiated 
into branched mycelium, similar to fungal hyphae (e.g., Streptomyces spp.) (Barka et al., 
2016; Ventura et al., 2007). Some species have the capacity to reproduce through the 
production of spores, sporangiospores or conidiophores. Spores are the main form of 
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reproduction and are produced on a large scale. Each spore has the possibility of 
germinating and growing so that a new microorganism is developed. Although not very 
resistant to heat, sporangiospores and conidiophores are resistant to dehydration and aid 
in the survival of species during drought. Other species, such as the genus Nocardia, 
multiply by fragmentation of hyphae in various bacilliform cells or cocci, each with the 
capacity to produce a new mycelium (Ventura et al., 2007).  
Actinobacteria are mostly aerobic, although some genera may be microaerophilic or 
anaerobic (Ventura et al., 2007). Metabolically, they can be heterotrophic, autotrophic, 
chemotrophic or phototrophic (Goodfellow & Williams, 1983; Stach & Bull, 2005). In 
addition, these microorganisms exhibit important metabolic traits, like the production of 
molecules with relevant bioactive properties, extracellular enzymes and various types of 
pigments (Schrempf, 2001). 
 Environmental distribution of actinobacteria 
Actinobacteria have adapted to many ecosystems and are present in both terrestrial and 
aquatic (fresh and salt water) environments and in the air. However, they are more 
predominant in the soil, where they have an important contribution for organic matter 
decomposition, including environmental pollutants (Ventura et al., 2007). This group of 
microorganisms was originally isolated from soils and was proven to be very important for 
human and veterinary medicine, biotechnology and ecology, mainly because these 
microorganisms are a source of compounds with high bioactive potential (Barka et al., 
2016). More than 10 000 of currently known antibiotics are derived from the secondary 
metabolism of several species of actinobacteria (Montalvo et al., 2005). Due to the 
remarkable history of actinobacteria as producers of bioactive compounds, considerable 
efforts have been made by the scientific community to isolate new actinobacteria for drug 
screening programs (Montalvo et al., 2005). 
Until recently, actinobacteria were only considered soil-dwelling microorganisms. The 
isolation of these microorganisms from marine samples initially led to the idea that they 
would come from resistant spores of terrestrial actinobacteria. However, Jensen et al. 
(1991) provided scientific evidence that actinobacteria isolated from tropical marine 
sediments were native to the marine environment, thus making this ecosystem an 
attractive and promising source of new actinobacteria. 
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 Marine environment 
The marine environment can be separated into coastal habitats and open ocean habitats. 
These habitats can range from the sea surface to the pelagic zone, which begins below 
the tidal influence zone, extending to the high seas, reaching depths of over 10 000 meters 
(Ward & Bora, 2006). The seafloor is constituted by sediments of diverse geology, 
carbonate structures, mineral nodules fields, cold seeps, saturated brines, hydrocarbon 
infiltrations and hydrothermal vents. It presents a micro and macrofauna with diverse biotic 
relationships, such as symbiosis and epibiosis (Ward & Bora, 2006). Oceans are 
ecosystems with unique characteristics in terms of pressure, salinity, temperature and 
oxygen concentrations (Manivasagan et al., 2013). These environmental pressures 
together with the huge biodiversity found in these ecosystems, have fostered the 
development over the years of distinct microbial physiological characteristics to ensure 
survival of microorganisms in this dynamic environment, one of them being the production 
of a high diversity of bioactive metabolites (Gulder & Moore, 2009). 
Due to its distinctive characteristics, the marine environment is therefore an excellent 
source to explore new species of actinobacteria (Manivasagan et al., 2014). These 
microorganisms are very important components of marine bacterial communities, 
presenting a wide distribution throughout marine ecosystems (Fig.1) (Abdelmohsen et al., 
2014). In recent years, new species of marine actinobacteria with unique metabolic 
capabilities have been discovered (Fenical & Jensen, 2006). Therefore, the proven 
indigenous character of marine actinobacteria, their high abundance and diversity, 
together with their prodigious capacity to produce secondary metabolites, make the marine 
environment a wealthy source of new bioactive compounds (Das et al., 2007; Jensen et 
al., 2005; Subramani & Aalbersberg, 2012). 
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 Marine sediments 
Marine sediments represent one of the major biomes on Earth, however little is known 
about their taxonomic and functional microbial diversity. They have a number of microbial 
cells many times higher than seawater, being considered one of the marine habitats with 
the highest rates of microbial diversity. The characteristics of marine sediments promote 
the development of microenvironments where bacteria interact and compete trough 
mechanisms such as the production of secondary metabolites (Patin et al., 2017).  
The research of actinobacteria in marine sediments has been a subject of attention in the 
last decade due to a significant development of techniques for the isolation and 
identification of native marine microflora. As a result, novel genera of actinobacteria have 
emerged, having a great potential for the discovery of new bioactive compounds with 
pharmaceutical and industrial interest (Jensen et al., 2005). Examples of these promising 
Figure 1 - Distribution of actinobacteria in the marine environment (the study took into account a total of 
10.400 16S rRNA gene sequences of marine actinobacteria). Adapted from Abdelmohsen et al. (2014). 
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novel genera include: Salinispora, Demequina, Aestuariimicrobium, Sciscionella, 
Marinactinospora, Paraoerskovia, Marisediminicola, Miniimonas, Spinactinospora, 
Sediminihabitans, Flaviflexus, Mariniluteicoccus and Halopolyspora (Claverias et al., 
2015). Knowledge of actinobacterial diversity in marine sediments has increased thanks to 
the cultivation of these microorganisms from marine sediment samples taken from various 
depths (Maldonado et al., 2005b). Thus, it has been possible to improve the knowledge on 
the taxonomy and geographical distribution of these microorganisms as well as to isolate 
new actinobacteria with biotechnological potential (Maldonado et al., 2005a; Maldonado et 
al., 2005b; Ward & Bora, 2006) 
 Sponges  
The phylum Porifera, commonly known as sponges, includes the oldest animal group living 
on our planet. Sponges mainly inhabit marine habitats, but may also be present in fresh 
waters. They are sedentary feeders, with most marine sponges being benthonic and 
filtering organisms. Capable of pumping thousands of liters of water per day, sponges 
capture planktonic organisms from seawater through continuous water transportation to 
their interior (Hentschel et al., 2012; Van Soest et al., 2012). 
Over the years, sponges have established great symbiotic relationships with 
microorganisms (bacteria, archaea and fungi). The microbial biomass can constitute up to 
35% - 40% of the sponge’s volume (Schmitt et al., 2012; Webster & Taylor, 2012) . So far, 
32 bacterial phyla have been reported to be associated with marine sponges, with the 
most abundant being Proteobacteria, Actinobacteria, Chloroflexi, Firmicutes, 
Bacteriodetes, Cyanobacteria and Acidobacteria (Fig.2) (Schmitt et al., 2012).  
Marine sponges have a well-developed immune system. For their defense, marine 
sponges produce a wide range of bioactive compounds to protect against various threats, 
such as predators, microbial infestations,  to prevent the growth of sessile organisms etc. 
(Hentschel et al., 2012; Suthindhiran et al., 2014), though scientific evidences indicate that 
many of these compounds may be actually produced by their symbiont microorganisms 
(Mehbub et al., 2014). Together, marine sponges and their symbiotic microorganisms have 
a remarkable chemical repertoire, which has been drawing the attention of the 
pharmaceutical industry (Hentschel et al., 2012). 
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Figure 2 - Phylogenetic distribution of sponge‐associated bacteria (considering a total of 11 
284 16S rRNA gene sequences retrieved from GenBank). Source: (Webster & Taylor, 2012). 
 
 
 
 
 
 
Marine actinobacteria have been isolated from diverse species of sponges and these 
organisms have been found to host important actinobacterial genera, as is the case of the 
novel genus Salinospora (Kim et al., 2006). In addition, sponge-associated actinobacteria 
have been reported to produce secondary metabolites with a wide range of biological 
activities (Abdelmohsen et al., 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Marine actinobacteria 
Marine actinobacteria are known for their great ability to produce secondary metabolites 
with biological activity. The potential is so high that a single strain may have the ability to 
produce 10-20 different secondary metabolites. It is estimated that about 25 000 – 27 000 
antibiotics are produced by microorganisms and that from these, about 10 000 (ca. 40%) 
are produced by actinobacteria (Berdy, 2012). Approximately 67% of the natural products 
produced by marine actinobacteria come from microorganisms isolated from Coral Sea, 
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Yellow Sea, Indian Ocean, Mediterranean Sea and Pacific Ocean (Manivasagan et al., 
2013). 
Several studies have shown the existence of actinobacteria native to the marine 
environment, belonging to various genera, such as, Micromonospora, Streptomyces, 
Actinomadura, Actinosynnema, Amycolatopsis, Kitasatospora, Micrococcus, 
Microbacterium, Nocardioides, Nocardiopsis, Nonomurea, Tsukamurella, and Williamsia 
(Manivasagan et al., 2014; Ward & Bora, 2006).  
Recently the genera Salinispora, Marinispora and Verrucosispora have also been 
reported, and their members were found to require sea water to grow. The genus 
Salinibacterium is another example recently reported, whose species tolerate NaCl 
concentrations up to 10%, but do not require the presence of salt for their growth (Bruns et 
al., 2003; Han et al., 2003; Kwon et al., 2006a; Maldonado et al., 2005a; Riedlinger et al., 
2004). Many of these genera are capable of producing unique bioactive compounds such 
as antimicrobial, antifungal, anticancer, antitumor, anti-inflammatory, anti-viral, anti-
malarial, antioxidant, cytotoxic, antialgal and anti-angiogenesis agents (Table 1) 
(Manivasagan et al., 2014). 
 
 Table 1. Examples of secondary metabolites produced by marine actinobacteria (adapted from Manivasagan et al. 
2014). Different colors in the Table indicate different bioactivities 
Compound Species Biological activity Reference 
Abyssomicins Verrucosispora sp. Antibacterial Riedlinger et al. (2004) 
Bonactin Streptomyces sp. Antibacterial; antifungal Schumacher et al. (2003) 
Chloro-dihydroquinones Streptomyces sp. Antibacterial; anticancer 
Soria-Mercado et al. 
(2005) 
Diazepinomicin Micromonospora sp. 
Antibacterial; anticancer; 
Anti-inﬂammatory 
Charan et al. (2004) 
Frigocyclinone 
Streptomyces 
griseus 
Antibacterial Bruntner et al. (2005) 
Essramycin Streptomyces sp. Antibacterial El-Gendy et al. (2008) 
Lynamicins Marinispora sp. Antibacterial McArthur et al. (2008) 
Marinopyrroles Streptomyces sp. Antibacterial; cytotoxic Hughes et al. (2008) 
Caboxamycin Streptomyces sp. Antibacterial; cytotoxic Hohmann et al. (2009c) 
Himalomycins Streptomyces sp. Antibacterial Maskey et al. (2003a) 
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Marinomycins Marinispora 
Antibacterial; antifungal; 
anticancer 
Kwon et al. (2006b) 
Glyciapyrroles Streptomyces sp. Antibacterial Macherla et al. (2005) 
Tirandamycin Streptomyces sp. Antibacterial Carlson et al. (2009) 
Bisanthraquinone Streptomyces sp. Antibacterial Socha et al. (2006) 
Gutingimycin Streptomyces sp. Antibacterial Maskey et al. (2004b) 
Helquinoline Janibacter limosus Antibacterial Asolkar et al. (2004) 
Lajollamycin 
Streptomyces 
nodosus 
Antibacterial Manam et al. (2005) 
TP-1161 Nocardiopsis sp. Antibacterial Engelhardt et al. (2010) 
Lincomycin 
Streptomyces 
lincolnensis 
Antibacterial Peschke et al. (1995) 
1,4-Dihydroxy-2-(3-
hydroxybutyl)-9,10- 
anthraquinone 9,10-anthrac 
Streptomyces sp. Antibacterial Ravikumar et al. (2012b) 
Chandrananimycin Actinomadura sp 
Antifungal; antialgal; 
antibacterial; anticancer 
Maskey et al. (2003b) 
N-(2-hydroxyphenyl)-2-
phenazinamine (NHP) 
Nocardia 
dassonvillei. 
Antifungal; anticancer Gao et al. (2012) 
Salinosporamide A Salinispora tropica Anticancer Feling et al. (2003) 
Caprolactones Streptomyces sp. Anticancer Stritzke et al. (2004) 
3,6-Disubstituted indoles Streptomyces sp. Anticancer López et al. (2003) 
IB-00208 Actinomadura sp. Anticancer Rodriguez et al. (2003) 
1- Hydroxy-1-
norresistomycin 
Streptomyces 
chinaensis 
Anticancer; antibacterial 
Gorajana et al. (2005) 
and Kock et al. (2005) 
ZHD-0501 Actinomadura sp. Anticancer Han et al. (2005) 
Chinikomycins Streptomyces sp. Antitumor  Li et al. (2005) 
Glyciapyrroles Streptomyces sp. Antitumor  Macherla et al. (2005) 
Mechercharmycin A 
Thermoactinomyces 
sp 
Antitumor  Kanoh et al. (2005) 
Aureoverticillactam 
Streptomyces 
aureoverticillatus 
Antitumor  Mitchell et al. (2004) 
Arenicolides 
Salinispora 
arenicola 
Antitumor  Williams et al. (2007) 
Chalcomycin Streptomyces sp. Antitumor  Asolkar et al. (2002) 
Daryamides Streptomyces sp. Antitumor  Asolkar et al. (2006) 
Aureolic acid Streptomyces sp. Antitumor  Lu et al. (2012) 
1,8-Dihydroxy-2-ethyl-3-
methylanthraquinone 
Streptomyces sp. Antitumor  Huang et al. (2006) 
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Arenimycin 
Salinispora 
arenicola 
Antitumor; antibacterial Asolkar et al. (2010b) 
Mitomycin C 
Streptomyces 
lavendulae 
Antitumor Mao et al. (1999) 
Staurosporinone Streptomyces sp. Antitumor; phycotoxicity Wu et al. (2006) 
Streptokordin Streptomyces sp. Antitumor  Jeong et al. (2006) 
Elaiomycins B and C Streptomyces sp. Antitumor  Helaly et al. (2011) 
Manumycins Streptomyces sp. Cytotoxic  Chauhan et al. (2005) 
Salinipyrones Salinispora paciﬁca Cytotoxic  Oh et al. (2008) 
Paciﬁcanones Salinispora paciﬁca Cytotoxic  Oh et al. (2008) 
Actinofuranones Streptomyces Cytotoxic  Cho et al. (2006) 
Nonactin Streptomyces sp. Cytotoxic  Jeong et al. (2006) 
Resistoﬂavine 
Streptomyces 
chibaensis 
Cytotoxic  Gorajana et al. (2007) 
Neomarinones Actinomycetales Cytotoxic  Hardt et al. (2000) 
Piericidins Streptomyces sp. Cytotoxic  Hayakawa et al. (2007) 
Lucentamycins 
Nocardiopsis 
lucentensis 
Cytotoxic  Cho et al. (2007) 
Arenamides Salinipora arenicola Cytotoxic  Asolkar et al. (2010a) 
Piperazimycins Streptomyces sp. Cytotoxic  Miller et al. (2007) 
Mansouramycin C Streptomyces sp. Cytotoxic  Hawas et al. (2009)  
Usabamycins Streptomyces sp. Cytotoxic  Sato et al. (2011) 
Pyridinium Amycolatopsis alba. Cytotoxic; antimicrobial Dasari et al. (2012) 
ML-449 (macrolactam) Streptomyces sp. Cytotoxic Jørgensen et al. (2010) 
Salinosporamide B & C Salinipora tropica Cytotoxic Williams et al. (2005) 
Albidopyrone Streptomyces sp. 
Cytotoxic (inhibitor of 
protein–tyrosine 
phosphatase) 
Hohmann et al. (2009a) 
Proximicins Verrucosispora sp. Cytostatic Schneider et al. (2008) 
Cyclomarins 
Streptomyces sp. 
and  
Salinispora 
Arenicola 
Anti-inﬂammatory 
Renner et al. (1999) and 
Schultz et al. (2008) 
Salinamides A and B Streptomyces sp. Anti-inﬂammatory Moore et al. (1999) 
Avermectins 
Streptomyces 
avermitilis 
Anti-inﬂammatory Burg et al. (1979) 
Trioxacarcin Streptomyces sp. 
Anti-malarial; 
antibacterial; antitumor 
Maskey et al. (2004a) 
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Benzastatin C 
Streptomyces 
nitrosporeus 
Anti-viral Lee et al. (2007) 
Dermacozines A-G Dermacoccus Antioxidant; antitumor;  
Abdel-Mageed et al. 
(2010) 
Lipocarbazoles 
Tsukamurella 
pseudospumae 
Antioxidant Schneider et al. (2009) 
2- Allyloxyphenol Streptomyces sp. 
Antioxidant; 
antimicrobial 
Arumugam et al. (2010) 
Streptopyrrolidine Streptomyces sp. Anti-angiogenesis Shin et al. (2008) 
Cyclo-(l-Pro-l-Met) Nocardiopsis sp. Anti-angiogenesis Shin et al. (2010) 
 
 Marine rare actinobacteria  
Due to the fact that, among actinobacteria, Streptomyces species are the most frequently 
isolated strains, isolation of other actinobacterial genera is an important step towards the 
discovery of new bioactive compounds (Cai et al., 2009). Rare actinobacteria are generally 
known as non-Streptomyces species, which frequency of isolation using traditional 
culturing methods is much lower comparing with Streptomyces strains. These 
microorganisms are reported to be well distributed in both terrestrial and aquatic 
ecosystems (Tiwari & Gupta, 2012). 
The research of rare actinobacteria combined with the exploration of poorly studied natural 
ecosystems has resulted in the isolation of approximately 220 rare genera, with a large 
fraction of these being responsible for the production of about 3000 bioactive compounds 
(Berdy, 2012; Tiwari & Gupta, 2012). In the marine environment, rare actinobacteria have 
been isolated from sediments, sea water, sponges, tunicates, seaweeds and marine 
mollusks, but a vast majority of marine ecosystems remain unexplored in terms of these 
bacteria (Dhakal et al., 2017; Subramani & Aalbersberg, 2013). Examples of rare marine 
actinobacteria genera include Nocardia, Nocardiopsis, Actinomadura, Micromonospora, 
Marinactinospora, Salinispora, Actinoalloteichus and Saccharomonospora, these 
microorganisms are responsible for the production of important bioactive compounds such 
as peptidolipins, with antibacterial activity against multiresistant bacteria, 
isomethoxyneihumicin, which has high cytotoxicity against leukemia cells, halomadurone, 
used for the treatment of neurodegenerative diseases,  anthracyclinones, with cytotoxicity 
against the human colon adenocarcinoma cell line, marthiapeptide A show antibacterial 
activity against Gram-positive bacteria and high cytotoxic activity, salinoquinones with 
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cytotoxic activity, caerulomycins exhibit cytotoxic activity against diverse cancerous cell 
lines and taromycin which show antibacterial activity (Dhakal et al., 2017; Fu et al., 2011; 
Fukuda et al., 2017; Liang et al., 2016; Murphy et al., 2010; Sousa et al., 2012; Wyche et 
al., 2012; Wyche et al., 2013; Yamanaka et al., 2014; Zhou et al., 2012). 
 Ecologic importance of actinobacteria in the marine environment 
The degradation and transformation of organic matter is a continuous process carried out 
by several microorganisms (Bruns et al., 2003; Heald et al., 2001). In addition to the high 
capacity for producing bioactive compounds, actinobacteria also play a key role in the 
recycling of nutrients in marine ecosystems, being essential for the mineralization of 
organic matter and fixation of mineral nutrients and nitrogen (Das et al. 2007; Haefner, 
2003).  
Several marine actinobacteria capable of degrading compounds such as agar, alginate, 
laminarin, cellulose, chitin (Pisano et al., 1992), petroleum and other hydrocarbons have 
been described (Manivasagan et al., 2013; Pisano et al., 1992). The genera Arthobacter, 
Brevibacterium, Corynebacterium and Nocardia are considered important microorganisms 
in the degradation of petroleum (Goodfellow & Williams, 1983). In addition, marine 
actinobacteria have also been reported to be capable of producing enzymes of great 
industrial and pharmaceutical interest (Ramesh & Mathivanan, 2009). Thus, it is important 
to assess the ecological role of marine actinobacteria, not only because of their ability to 
produce secondary metabolites with high biotechnological potential, but also due to their 
biodegradation capacity which can be exploited for the bioremediation of various 
pollutants. 
 Production of secondary metabolites by actinobacteria 
Actinobacteria produce a diverse array of secondary metabolites with high 
biotechnological relevance and their production may be increased through the optimization 
of fermentation conditions (Sujatha et al., 2005). Synthesis of secondary metabolites is 
only initiated when growth of these microorganisms starts to slow down or is stopped (after 
primary metabolism). For this reason, the synthesis of these metabolites is influenced by 
factors directly related to microbial growth, such as nutrient availability, nitrogen or 
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phosphorus concentration in the medium, pH, temperature, oxygen partial pressure, 
agitation, mineral salts and metal ions available and presence of precursors, inducers or 
inhibitors, (Manivasagan et al., 2013). The synthesis of secondary metabolites by 
actinobacteria is related to cell growth as follows: (i) adaptation phase (lag phase) - growth 
is almost absent and protein production is induced as a response to surrounding 
conditions; (ii) exponential growth phase (log phase) - there is an intense microbial growth, 
with synthesis of secondary metabolites being scarce; (iii) transition phase - growth and 
protein synthesis are repressed, synthesis of secondary metabolism enzymes is intensified 
thus initiating the production of secondary metabolites; (iv) production phase - growth rate 
is reduced, dry weight remains similar and the production of secondary metabolites is 
maximal (Bibb, 2005; Demain, 1998; Manivasagan et al., 2013). 
The production of these secondary metabolites is mediated by large enzymatic complexes, 
namely polyketide synthases (PKS) and nonribosomal peptide synthases (NRPS). PKS 
mediate the production of polyketides through sequential decarboxylative condensations of 
small building blocks of acetate or other small carboxylic acids. An individual PKS enzyme 
may consist in one or more functional modules, which comprise several domains, such as 
β-ketoacyl synthase, acyltrasnferase and acyl carrier proteins. Most of these enzymes also 
contain optional domains, such as β-ketoacyl reductase, dehydratase, enoylreductase and 
methyltransferase (Du & Lou, 2010; Khan et al., 2014). NRPS are a group of 
multifunctional enzymes, which synthesize peptides in a modular structure, through 
several domains such as adenylation, condensation and peptidyl carrier proteins, though 
other domains may be also associated with these enzymes (Du & Lou, 2010; Jenke-
Kodama & Dittmann, 2009).  
The molecules built by PKS or NRPS are then finished by tailoring enzymes, such as 
glycosyltransferases, methyltransferases, acyltransferases, prenyltransferases, 
transaminases, cyclases, halogenases, ketoredutases and oxygenases. Within these 
reactions, halogenation is a particularly important reaction for the bioactivity of a large 
number of natural compounds (Li et al., 2013).  
1.9.1. Secondary metabolites with antibacterial activity 
Bacterial infections by antibiotic-resistant bacteria are one of the leading causes of death 
worldwide. In order to overcome this problem, it is urgent to discover new effective 
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antibacterial substances with minimal side effects (Manivasagan et al., 2014; Ravikumar et 
al., 2012a) 
Marine actinobacteria have been found to be a potent resource of secondary metabolites 
with antibacterial activity. Examples include Abyssomycin C, a polycyclic polyethylene 
antibiotic produced by a marine strain of Verrucosispora sp. (Riedlinger et al., 2004), 
acting against Gram-positive clinical isolates (Hassan et al., 2017; Manivasagan et al., 
2014); Bonactin, isolated from the liquid culture of a Streptomyces sp. strain, exhibiting 
antimicrobial activity against Gram-negative bacteria and fungi; Diazepinomycin produced 
by a Micromonospora sp., with antibacterial activity against  Gram-positive bacteria 
(Charan et al., 2004); Essramycin, an antibacterial compound isolated from a strain of 
Streptomyces griseus and with a high activity against Gram-positive bacteria (Bruntner et 
al., 2005) and Carboxamycin, an antibiotic isolated from extracts of a Streptomyces sp., 
exhibiting antibacterial activity against Gram-positive bacteria (Hohmann et al., 2009b). 
1.9.2. Secondary metabolites with anticancer activity 
Cancer is a disease that affects thousands of people worldwide and its incidence is 
increasing over the years. Most anticancer drugs currently used cause side effects by 
damaging healthy cells and tissues, and for many cancers no effective treatment is 
available. Marine bacteria play a major role in the production of secondary metabolites 
with anticancer activity. Examples illustrated in the literature include Salinosporamide A, a 
novel bicyclic beta-lactone gamma-lactam isolated from Salinispora tropica, which shows 
cytotoxicity in many malignant cell types (Jensen et al., 2007); Caprolactones, an antibiotic 
isolated from a strain of Streptomyces sp. that also shows activity against cancerous cells 
and low cytotoxicity in normal cells (Stritzke et al., 2004); Streptoanthraquinone A, a 
polycyclic anthraquinone recovered from Streptomyces sp. which has activity against four 
different glioma cell lines (Liang et al., 2016); Dehydrorabelomycin and 
Phenanthroviridone produced by Micromonospora sp. and showing varying degrees of 
cytotoxicity against several cancerous cell lines (Mullowney et al., 2015). 
 Aim and outline of this thesis 
The search for new drugs to combat diseases for which treatments are inexistent or no 
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longer effective is an urgent topic. Natural products from marine actinobacteria have been 
explored to meet this urgent need for new drugs. In this context, the present master's 
thesis aimed at the isolation of actinobacteria from marine environments, namely from 
marine sediment and a sponge belonging to the species Hymeniacidon perlevis, and 
investigation of their potential to produce bioactive compounds with antimicrobial or 
anticancer activities. 
The thesis is organized in 4 chapters. Chapter 1 consists in a general introduction to 
theme of the thesis, where several aspects related with actinobacteria are described, 
mainly focusing in marine actinobacteria, their environmental distribution, most relevant 
genera, secondary metabolism and main metabolites produced with antibacterial and 
anticancer activities.  Chapter 2 describes a study on the isolation of actinobacteria from 
marine sediment collected from the northern Portuguese coast and investigation of their 
potential to produce compounds with antimicrobial or anticancer activity. Chapter 3, focus 
on the isolation and identification of rare actinobacteria from the marine sponge H. 
perlevis, obtained from the intertidal zone of the northern Portuguese coast and Chapter 4 
consists in a general discussion and main conclusions of the work presented in this thesis. 
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CHAPTER 2  
ISOLATION AND INVESTIGATION OF  BIOACTIVE 
POTENTIAL OF ACTINOBACTERIA FROM 
PORTUGUESE MARINE COASTAL SEDIMENT 
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 Introduction 
Multidrug-resistant bacterial infections and cancer are at the top of diseases for which 
novel therapies are required. The increase of antibiotic resistant microorganisms is mainly 
caused by the extensive and uncontrolled use of antibiotics, transfer of genes between 
species and microbial evolution (Duncan et al., 2015). This problem compromises the 
efficacy of currently available antibiotics, leading to a growing need of finding new 
therapeutic agents with different mechanisms of action (Undabarrena et al., 2016). On the 
other hand, most anticancer drugs currently used to treat several types of cancer diseases 
cause undesirable side effects, damaging healthy cells and tissues while killing cancer 
cells, and for many types of cancer there is still no effective treatment available, being 
urgent to discover new molecules with novel anticancer actions and less side effects 
(Duncan et al., 2015) .  
Natural products represent a large and diverse family of chemicals with different biological 
properties (Katz & Baltz, 2016). Currently, about 34,000 natural products have been 
characterized and, although they have different origins, the highest percentage of these is 
produced by bacteria (Berdy, 2012). In the last decades, more than 50% of all approved 
drugs were from natural origin or inspired in natural molecules, mainly derived from 
terrestrial organisms (Berdy, 2012; Newman & Cragg, 2016; Spainhour, 2005). 
The phylum Actinobacteria constitutes a group of Gram-positive bacteria with diverse 
physiological and morphological characteristics, usually sharing a high genomic content of 
guanine+cytosine (Chen et al., 2016). Microorganisms belonging to this phylum are 
important constituents of microbial communities of terrestrial and marine environments, 
contributing to the decomposition of organic compounds, nutrient recycling, nitrogen 
fixation, among others (Barka et al., 2016; Das et al., 2007; Manivasagan et al., 2013). In 
addition to their important environmental role, these microorganisms, and especially the 
ones belonging to the class Actinobacteria (hereinafter referred as actinobacteria), are 
very proficuous in the production of bioactive compounds with high pharmaceutical and 
industrial interest, being responsible for the producing of about 40% (ca. 13,700) of all 
bioactive microbial metabolites known. Among these, Streptomyces species are 
outstanding producers of bioactive compounds, producing ca. 76% of all the microbial 
metabolites derived from actinobacteria (e.g., streptomycin, rapamycin and tetracycline) 
(Berdy, 2005;2012; Manivasagan et al., 2013). Nonetheless, rare actinobacteria such as 
Micromonospora, Actinomadura, Actinoplanes, Streptoverticillium, Nocardia, 
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Saccharopolyspora and Streptosporangium, have also revealed to be important producers 
of bioactive compounds (Berdy, 2005; 2012). 
Microorganisms producing natural compounds have been intensively searched in 
terrestrial environments, leading to an overexploitation of these ecosystems and to a 
reduction in the chances of finding new bioactive molecules (Manivasagan et al., 2014). In 
the last years, a high interest in marine microorganisms has emerged not only for their 
taxonomic diversity and ecological importance, but also for their potential to produce new 
natural products (Dharmaraj, 2010). Oceans are home for a great diversity of 
microorganisms though a large majority of marine ecosystems is still unexplored in terms 
of actinobacterial diversity and, therefore, of new metabolites (Manivasagan et al., 2014). 
In fact, the indigenous character of marine actinobacteria has only been recently 
recognized and these microorganisms have proven to be an important source of bioactive 
compounds. Examples include marinomycins, produced by a Marinospora sp. and 
exhibiting antitumor and antibacterial activity; salinosporamide, resultant from the species 
Salinispora tropica and a potent anticancer agent and the antibiotic abyssomicin produced 
by Verrucosispora maris  (Manivasagan et al., 2013;2014; Subramani & Aalbersberg, 
2012; Ward & Bora, 2006).  
Marine sediments of the Atlantic Ocean are very poorly explored (Prieto-Davó et al., 2016) 
and this includes the vast maritime territory of Portugal for which the associated 
actinobacterial population is scarcely studied. Such underexplored environments offer an 
excellent opportunity to access novel microorganisms, thus increasing the prospects of 
finding new natural compounds with bioactivity (Claverias et al., 2015). 
In this study, a sediment sample collected from the intertidal zone of a beach located in 
Parque Natural do Litoral Norte, in northern Portugal, was used to investigate the 
associated actinobacteria and their bioactivity potential, through a cultivation-dependent 
approach. The Parque Natural do Litoral Norte is a protected area of Portugal that extends 
along 16 km of coast. This site was chosen because it has minimal anthropogenic 
intervention, with the inherent microbial communities being almost exclusively affected by 
natural processes. The main objectives of this study were to isolate and identify the 
actinobacterial population associated with the collected marine sediment and to investigate 
their ability to produce bioactive compounds with antimicrobial or anticancer activities.  
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 Materials and Methods 
 Sample collection  
A sample of marine sediment was collected at a depth of 0.15 m in the intertidal zone of 
Cepães beach located in Parque Natural do Litoral Norte, in the coastal area of Northern 
Portugal (41°33'11.5"N 8°47'38.1"W). The sample was transferred to a sterile plastic bag, 
transported to the laboratory in a cooling box and processed within an interval of two 
hours. 
 Isolation of actinobacteria 
Before inoculation onto isolation media, the sediment sample was processed using three 
different methods: dilution of 1 g of sediment in 9 mL of filtered seawater (method 1); 
dilution of 1 g of sediment in 9 mL of filtered seawater followed by incubation in a water 
bath at 60 ºC for 10 min (method 2); dilution of 5 g of sediment in 15 mL of filtered 
seawater and incubation with 20 mgL-1 of nalidixic acid and 20 mgL-1 of cycloheximide, at 
28 °C for 30 min (method 3). Samples resulting from these three methods were ten-fold 
diluted to 10-5 and an aliquot of 100 µl of each dilution was spread over the surface of the 
following selective isolation media: M3 agar (per liter of distilled water): 0.466 g of KH2P04, 
0.732 g of Na2HPO4, 0.10 g of KNO3, 0.29 g of NaCl, 0.10 g of MgSO4.7H2O, 0.02 g of 
CaCO3, 200 μg of FeSO4.7H20, 180 μg of ZnSO4.7H2O, 15 μg of MnSO4.4H20, 4 mg of 
thiamine HCl (Vitamin B1) and 17 g of agar; Nutrient-poor sediment extract (NPS) (per liter 
of seawater): 100 mL of marine sediment extract (obtained by washing 900 mL of 
sediments with 500 mL of seawater) and 17 g of agar; Starch-casein-nitrate agar (SNC) 
(per liter of distilled water): 10 g of soluble starch, 0.3 g of casein, 2 g of K2HPO4, 2 g of 
KNO3, 2 g of NaCl, 0.05 g of MgSO4.7H2O, 0.02 g of CaCO3, 0.01 g of FeSO4.7H20 and 17 
g of agar. All media were supplemented with cycloheximide (50 mgL-1) and streptomycin 
(50 mgL-1) in order to inhibit the growth of fungi and Gram-negative bacteria. The plates 
were incubated for six weeks at a temperature of 28 °C.  
Along the incubation period, plates were periodically inspected by visual observation and 
all colonies with different morphological characteristics were picked and re-streaked 
numerous times in the same agar medium until obtainment of pure colonies. Each isolate 
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was cryopreserved at -80 ºC in 30% glycerol. Before the cryopreservation step, each 
isolate was grown in liquid ISP2 medium or in Marine broth (Laboratorios Conda, S.A) in 
order to obtain enough biomass for cryopreservation (Table 2). The ISP2 medium had the 
following composition (per liter of seawater): 4 g of yeast extract, 10 g of malt extract, 4 g 
of glucose and 17 g of agar. The two media used were supplemented with the same 
antibiotics described above.  
 Identification of isolated strains by 16S rRNA gene sequencing 
Genomic DNA was extracted from all isolated microorganisms though the phenol-
chloroform method, as described elsewhere (Pereira et al., 2010). To obtain biomass for 
DNA extraction, each isolate was grown in 5 mL of liquid ISP2 medium or Marine broth 
(Table S1), at 25 ºC, 100 rpm, for one week. Biomass pellet was obtained for each isolate 
by centrifugation of 2 ml broth (7,000 x g for 5 min).  
16S rRNA gene was amplified by PCR, using the universal primers 27F (5'-
GAGTTTGATCCTGGCTCAG-3') and 1492R (5'-TACGGYTACCTTGTTACGACTT-30') 
(Lane, 1991). The PCR mixture (total volume of 10 μL) contained: 5 μL of Taq PCR Master 
Mix (Qiagen, Valencia, CA), 1 μL of primer 27F (2 µM), 1 μL of primer 1492R (2 µM) and 3 
μL of DNA template. PCR conditions were as following: initial denaturation at 95 °C for 15 
min, followed by 30 cycles at 94 °C for 30 s, 48 °C for 90 s, 72 °C for 90 s and a final 
extension at 72 °C for 10 min. PCR products were separated on a 1.5% agarose gel 
containing SYBR Safe (ThermoFisher Scientific, USA), at 150 V for 30 min. Purification 
and sequencing of the amplified DNA was performed by GATC Biotech (European 
Genome and Diagnostics Centre, Constance, Germany). The obtained 16S rRNA 
sequences were analyzed using the Geneious software, version 4.8.2 and the resulting 
consensus sequences were compared to the GenBank database using the blastn 
algorithm. The consensus sequences were additionally compared with the databases 
EzTaxon (http://www.ezbiocloud.net/) and Ribosomal Database Project 
(https://rdp.cme.msu.edu/index.jsp) in order to confirm the results obtained in the GenBank 
database. 
All the sequences and their five closest neighbor sequences in Genbank were aligned 
using the Geneious software. Phylogenetic trees were made individually for each phylum.  
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All alignments were used to generate a Maximum Likelihood phylogenetic tree of 1112bp 
for the phylum Actinobacteria, 1045bp for the phylum Firmicutes, 1365bp for phylum 
Proteobacteria and 1237bp for phylum Bacteroidetes, performed as the defaults of the 
ATCG South of France bioinformatics platform (http://www.atgc-montpellier.fr/) with 100 
bootstraps 
Sequences of MS8A1, MS40A, MS50 and MS58 strains belonging to the actinobacteria 
phylum and sequences of the MS7J, MS10G, MS13, MS22A, MS26F and MS57 strains 
belonging to the Firmicutes phylum were not included in the trees because they had 
sequences of <900bp.  
 Preparation of crude extracts from actinobacterial cultures for 
bioactivity tests 
In order to test the bioactivity potential, namely antimicrobial and anticancer activities, of 
the isolated actinobacterial strains, each isolate was grown in 250 mL Erlenmeyer flasks 
containing 100 mL of ISP2 medium or Marine broth (Laboratorios Conda, S.A) (Table 2). 
The flasks were incubated at 25 ºC, 100 rpm, in the dark. Cultures were grown for 1-2 
weeks, depending on their growth rate, after which 1.5 g Amberlite® XAD16N resin 
(Sigma-Aldrich, St. Louis, Mo.) were added to the cultures and left to incubate for an 
additional period of one week. Cultures were extracted twice with a solution of 
methanol/acetone 1:1 ratio (v/v). The organic layer was dried in a rotary evaporator and 
the resulting extract was dissolved in DMSO to obtain stock solutions with final 
concentrations of 3 mg mL-1 and 1 mg mL-1, to be tested in the bioactivity assays. 
 Anticancer Bioactivity Screening 
The actinobacterial extracts were tested against two cancer cell lines: breast ductal 
carcinoma (T-47D) and neuroblastoma (SH-SY5Y), both from Sigma-Aldrich (St. Louis, 
Missouri, USA). Cells were grown in Dubelco's Modified Eagle Medium (DMEM) from 
Gibco (Thermo Fischer Scientific, Waltham, Massachusetts, USA) supplemented with 10% 
(v/v) fetal bovine serum (Biochrom, Berlin, Germany), 1% (v/v) penincillin/streptomycin 
(Biochrom) at 100 IU/mL and 10 mg/mL, respectively, and 0.1% (v/v) amphotericin (GE 
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Healthcare, Little Chafont, United Kingdom) The cells were incubated at 37 °C in a 
humidified atmosphere containing 5% of CO2. 
Cell viability was assessed by the MTT assay ((3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide). The cells were seeded in 96-well plates at a density of 
6.6×104 cells mL-1. After 24 h, cells were exposed to the extracts at a final concentration 
30 µg mL-1. Negative and positive controls consisted in 0.5% dimethyl sulfoxide (DMSO, 
Sigma-Aldrich, USA) and 20% DMSO, respectively. Cell viability was assed at 24 and 48 h 
by adding MTT at a final concentration of 0.2 mg mL-1 and incubating for 4 h at 37 °C. The 
medium was then removed and 100 μL of DMSO were added per well, after which the 
absorbance was read at 570 nm (Synergy HT, Biotek, USA). Cellular viability was 
expressed as a percentage relative to the negative control. The assays were performed in 
triplicate.  
  Antimicrobial bioactivity screening  
The screening of antimicrobial activity in the obtained actinobacterial extracts was 
performed using the agar-based disk diffusion method. The extracts were tested against 5 
reference microorganisms: Staphylococcus aureus (ATCC 29213), Bacillus subtilis (ATCC 
6633), Escherichia coli (ATCC 25922), Salmonella typhimurium (ATCC 25241) and 
Candida albicans (ATCC 10231). The bacterial strains were grown in Mueller-Hinton agar 
(MH; BioKar diagnostics) and the yeast, C. albicans, was grown in Sabouraud Dextrose 
agar (SD; BioKar diagnostics). Colonies of test organisms were suspended in the 
corresponding media broth and the turbidity of the cultures was adjusted to 0.5 McFarland 
standard (OD625= 0.08−0.13). These standardized suspensions were used to seed MH or 
SD (for C. albicans) agar plates, by evenly streaking the plates with a swab dipped in the 
inoculum cultures. Blank paper discs (6mm in diameter; Oxoid) were placed in the surface 
of the inoculated plates and loaded with 15 μl of each extract at the concentration of 1 mg 
mL-1. Negative controls consisted in loading the paper disks with 15 μl of DMSO at 1 mg 
mL-1. The assays were performed in duplicate. Agar plates were incubated at 37°C for 24 
h, after which the presence of inhibition zone diameters was inspected. Minimal inhibitory 
concentration (MIC) was only determined for extracts showing inhibition halos. Inoculum 
suspension of the reference microorganism C. albicans was prepared as above. Stock 
solutions of extracts were prepared in the medium broth SD at the concentration of 500 µg 
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mL-1 and ten two-fold dilutions were successively performed from these stocks, resulting in 
extracts concentrations ranging from 250 to 0.487 µg mL-1. The assay was performed in 96 
well plates, in which each well was filled with 50 μL of microbial inoculum (diluted 1:100) 
and 50 μL of each extract dilution. Positive control consisted in filling the wells with 50 μL 
of microbial inoculum and 50 μL of medium broth and negative controls consisted in filling 
the wells with 100 μL of medium broth. Dilutions of each extract were tested in triplicate. 
MIC was determined by spectrophotometric analysis (at 625 nm), after 18 h of incubation 
at 37 °C. 
 Results  
The isolation of actinobacteria from a marine sediment sample collected on a beach 
situated in Parque Natural do Litoral Norte, Portugal, was carried out using three different 
treatments and three selective culture media. A total of 117 isolates with distinct 
morphological characteristics were obtained along an incubation period of six weeks. 
Many of these isolates exhibited traits characteristic of actinobacteria, such as colonies 
with a leather texture, growing inside the agar, slow growth, production of spores or 
hyphae and production of pigments leading in some cases to change of the color of the 
medium (Fig 3). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 - Examples of some isolates obtained from marine sediment collected from a beach in 
Parque Natural do Litoral Norte. (A) Strain MS58, (B) strain MS55, (C) strain MS8B, (D) strain 
MS35, (E) strain MS14B, and (F) strain MS3C. 
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Taxonomic identification of all obtained isolates revealed that the treatments and culture 
media used in this study led to the isolation of microorganisms belonging to 4 different 
phyla: Actinobacteria, Firmicutes, Proteobacteria and Bacteroidetes (Fig 4 and Fig 5, Fig 
6, Fig 7 and Fig 8). The results of the identification of each isolate through 16S rRNA gene 
sequencing are indicated in Table 2 and the distribution of the identified genera according 
to their abundance, treatment methods employed and culture media used is shown in 
Figure 9.  
 
Within the phylum Actinobacteria, which was the focus of this study, the results revealed 
that the recovered isolates had a high phylogenetic diversity, belonging to 6 different 
families: Micromonosporaceae, Streptomycetaceae, Micrococcaceae, Microbacteriaceae, 
Nocardiopsaceae and Thermomonosporaceae and 7 genera: Micromonospora, 
Polymorphospora, Streptomyces, Arthrobacter, Herbiconiux, Nocardiopsis and 
Actinomadura, with the largest fraction of isolates being assigned to the genus 
Micromonospora (Fig. 9A). Interestingly, except for the genera Streptomyces, Arthrobacter 
and Herbiconiux all the other genera constitute rare actinobacterial genera. From the 
analysis of Fig. 9, it is also apparent that the three methods used to treat the marine 
Figure 4 – Distribution by phylum of the isolates recovered from the marine sediment collected on Parque 
Natural do Litoral Norte, Portugal. 
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sediment sample allowed a similar recovery of Micromonospora species, while a higher 
number of Streptomyces isolates was obtained with methods 1 and 2 (Fig. 9A2). It is 
notable that the vast majority of the actinobacterial isolates obtained were recovered from 
the medium NPS, with SCN retrieving a small fraction of actinobacteria and M3 medium 
showing no growth. (Fig. 9A3). 
Concerning the phyla Firmicutes, Proteobacteria and Bacteroides, isolates belonging to 
the first phylum were assigned to only two genera: Bacillus and Paenibacillus, (Table 2 
and Fig. 9B1), while for the Proteobacteria and Bacteroides phyla the few isolates 
recovered were found to: belong to 4 (Erythrobacter, Alterytrobacter, Devosia and 
Sphingorhabdus) and 3 (Leeuwenhokiella, Flexibacter and Maribacter) different genera, 
respectively (Table 2 and Figs. 9C1 and 9D1). The three treatments applied in the marine 
sediment sample did not seem to have influenced the recovery of Bacillus and 
Paenibacillus species, while these treatments appeared to have some influence in the 
recovery of the different genera belonging to the Proteobacteria and Bacteroides phyla 
(Fig. 9B2, 9C2 and 9D2). The medium that led to a higher number of Firmicutes, 
Proteobacteria and Bacteroides isolates was, once again, the NPS. Medium SCN only 
allowed the recovery of a few Bacillus species, while no isolates were grown in medium 
M3 (Fig. 9B3, 9C3 and 9D3).  
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Table 2 - Taxonomic identification of the isolates recovered from the marine sediment collected from a beach in Parque Natural do Litoral Norte. Different colors in 
the Table refer to microorganisms belonging to different phyla.  
Isolate 
Samplea 
processing 
method 
Isolation 
Medium 
Liquid medium 
used for growth 
Phylum Closest identification Similarity % 
MS3D1 Method 1 NPS Marine Broth Actinobacteria Streptomyces sp 100 
MS5D Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.3 
MS5E Method 1 NPS Marine Broth Actinobacteria Micromonospora aurantiaca 100 
MS19E Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.8 
MS19F Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.8 
MS23C Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.0 
MS23D Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.8 
MS26H Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.5 
MS26I Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.5 
MS32 Method 1 NPS ISP2 Actinobacteria Streptomyces zhaozhouensis 99.9 
MS35 Method 1 NPS ISP2 Actinobacteria Nocardiopsis sp 99.9 
MS42 Method 1 NPS Marine Broth Actinobacteria Micromonospora aurantiaca 100 
MS46 Method 1 NPS Marine Broth Actinobacteria Micromonospora peceutia 99.6 
MS48 Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.8 
MS49 Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.9 
MS50 Method 1 NPS Marine Broth Actinobacteria Micromonospora peucetia 99.4 
MS51 Method 1 NPS Marine Broth Actinobacteria Micromonospora sp. 99.8 
MS54 Method 1 NPS ISP2 Actinobacteria Streptomyces sp. 100 
MS3B Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 100 
MS3C1 Method 2 NPS Marine Broth Actinobacteria Micromonospora marina 99.8 
MS16B Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 99.8 
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MS18A Method 2 NPS ISP2 Actinobacteria Streptomyces sp 99.6 
MS18B Method 2 NPS Marine Broth Actinobacteria Streptomyces sp 100 
MS19 Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 99.2 
MS19A Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 99.9 
MS19B1 Method 2 NPS Marine Broth Actinobacteria Micromonospora aurantiaca 100 
MS19C Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 99.7 
MS19D Method 2 NPS Marine Broth Actinobacteria Micromonospora marina 99.6 
MS23A Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 99.6 
MS23B Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 99.7 
MS24 Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 99.6 
MS27A Method 2 NPS ISP2 Actinobacteria Streptomyces sp 99.9 
MS29 Method 2 NPS ISP2 Actinobacteria Streptomyces sp 100 
MS38 Method 2 SCN ISP2 Actinobacteria Herbiconiux solani 100 
MS52A Method 2 NPS Marine Broth Actinobacteria Micromonospora sp. 99.6 
MS52B Method 2 NPS Marine Broth Actinobacteria Micromonospora marina 99.0 
MS53 Method 2 NPS Marine Broth Actinobacteria Polymorphospora rubra 99.6 
MS3C Method 3 NPS Marine Broth Actinobacteria Micromonospora sp. 99.8 
MS3E Method 3 NPS Marine Broth Actinobacteria Micromonospora sp. 99.7 
MS5B Method 3 NPS Marine Broth Actinobacteria Micromonospora sp. 99.6 
MS5C Method 3 NPS Marine Broth Actinobacteria Micromonospora sp. 99.6 
MS8A1 Method 3 NPS ISP2 Actinobacteria Streptomyces sp. 99.7 
MS8B Method 3 NPS Marine Broth Actinobacteria Micromonospora sp 99.3 
MS8C Method 3 NPS Marine Broth Actinobacteria Micromonospora sp. 99.7 
MS14B Method 3 NPS Marine Broth Actinobacteria Streptomyces sp. 98.2 
MS39B Method 3 SCN ISP2 Actinobacteria Arthrobacter sp 99.8 
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MS39C Method 3 SCN ISP2 Actinobacteria Arthrobacter sp 99.8 
MS40A Method 3 SCN ISP2 Actinobacteria Arthrobacter sp 100 
MS40B1 Method 3 SCN ISP2 Actinobacteria Arthrobacter sp 99.8 
MS55 Method 3 NPS Marine Broth Actinobacteria Micromonospora aurantiaca 100 
MS56 Method 3 NPS Marine Broth Actinobacteria Micromonospora aurantiaca 99.6 
MS58 Method 3 NPS Marine Broth Actinobacteria Actinomadura sputi 99.6 
MS2I Method 1 NPS ISP2 Firmicutes Bacillus sp. 99.3 
MS3D2 Method 1 NPS ISP2 Firmicutes Bacillus sp. 99.7 
MS3H Method 1 NPS ISP2 Firmicutes Paenibacillus sp. 99.2 
MS7N Method 1 NPS ISP2 Firmicutes Bacillus sp. 99.3 
MS7S Method 1 NPS ISP2 Firmicutes Bacillus sp. 99.6 
MS7T2 Method 1 NPS ISP2 Firmicutes Bacillus licheniformis 99.8 
MS15B Method 1 NPS ISP2 Firmicutes Paenibacillus sp. 98.7 
MS23G Method 1 NPS ISP2 Firmicutes Paenibacillus sp. 98.6 
MS26D Method 1 NPS ISP2 Firmicutes Paenibacillus sp. 97.0 
MS26F Method 1 NPS ISP2 Firmicutes Paenibacillus sp. 99.3 
MS26K Method 1 NPS ISP2 Firmicutes Paenibacillus agarexendens 99.0 
MS31B Method 1 NPS ISP2 Firmicutes Paenibacillus sp. 98.4 
MS33 Method 1 NPS ISP2 Firmicutes Paenibacillus sp. 98.9 
MS45 Method 1 NPS ISP2 Firmicutes Bacillus sp. 99.5 
MS7J Method 2 NPS ISP2 Firmicutes Bacillus licheniformis 100 
MS7K Method 2 NPS ISP2 Firmicutes Bacillus sp. 99.8 
MS7L Method 2 NPS ISP2 Firmicutes Paenibacillus sp. 98.0 
MS7M Method 2 NPS ISP2 Firmicutes Bacillus sp. 99.4 
MS7P Method 2 NPS ISP2 Firmicutes Bacillus sp. 99.5 
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MS7O Method 2 NPS ISP2 Firmicutes Bacillus licheniformis 99.4 
MS7Q Method 2 NPS ISP2 Firmicutes Bacillus sp. 99.4 
MS7U Method 2 NPS ISP2 Firmicutes Bacillus licheniformis 99.5 
MS10D Method 2 NPS ISP2 Firmicutes Paenibacillus amylolyticus 99.1 
MS10G Method 2 NPS ISP2 Firmicutes Paenibacillus sp. 100 
MS10H Method 2 NPS ISP2 Firmicutes Paenibacillus sp. 99.2 
MS22A Method 2 NPS ISP2 Firmicutes Bacillus licheniformis 99.7 
MS25B Method 2 NPS ISP2 Firmicutes Paenibacillus sp. 99.6 
MS26B1 Method 2 NPS ISP2 Firmicutes Paenibacillus daejenonensis 99.4 
MS26C Method 2 NPS ISP2 Firmicutes Paenibacillus sp. 99.4 
MS27A Method 2 NPS ISP2 Firmicutes Paenibacillus sp. 99.8 
MS28A Method 2 NPS ISP2 Firmicutes Bacillus sp. 99.7 
MS2C Method 3 NPS ISP2 Firmicutes Paenibacillus xylanilyticus 98.8 
MS2D Method 3 NPS ISP2 Firmicutes Paenibacillus sp. 99.4 
SM2E Method 3 NPS ISP2 Firmicutes Paenibacillus sp. 98.4 
SM2F Method 3 NPS ISP2 Firmicutes Paenibacillus sp. 99.3 
MS6 Method 3 NPS ISP2 Firmicutes Paenibacillus agarexendens 99.2 
MS7A Method 3 NPS ISP2 Firmicutes Bacillus licheniformis 99.8 
MS7B Method 3 NPS ISP2 Firmicutes Bacillus licheniformis 99.7 
MS7C Method 3 NPS ISP2 Firmicutes Bacillus sp. 99.7 
MS7D Method 3 NPS ISP2 Firmicutes Bacillus sp. 99.7 
MS7E Method 3 NPS ISP2 Firmicutes Bacillus sp. 99.8 
MS7I Method 3 NPS ISP2 Firmicutes Bacillus sp. 99.4 
MS7V Method 3 NPS ISP2 Firmicutes Bacillus sp. 99.4 
MS8A2 Method 3 NPS ISP2 Firmicutes Bacillus paralicheniformis 99.5 
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MS11A Method 3 NPS ISP2 Firmicutes Paenibacillus xylanexedens 99.7 
MS12A Method 3 NPS ISP2 Firmicutes Paenibacillus sp. 99.2 
MS13 Method 3 NPS ISP2 Firmicutes Bacillus siralis 99.5 
MS14A Method 3 NPS ISP2 Firmicutes Bacillus paralicheniformis 99.8 
MS15A Method 3 NPS ISP2 Firmicutes Paenibacillus sp.. 99.0 
MS39A Method 3 SCN ISP2 Firmicutes Bacillus sp. 99.7 
MS57 Method 3 NPS ISP2 Firmicutes Bacillus clausii 99.5 
MS43 Method 1 NPS NPS Proteobacteria Devosia sp. 98.4 
MS20C Method 2 NPS NPS Proteobacteria Sphingorhabdus flavimaris 99.6 
MS21A Method 2 NPS NPS Proteobacteria Erythrobacter pelagi 99.4 
MS2C2 Method 3 NPS NPS Proteobacteria Erythrobacter sp. 100 
MS2E 1 Method 3 NPS NPS Proteobacteria Altererythrobacter sp. 97.9 
MS3A Method 3 NPS NPS Proteobacteria Erythrobacter longus 98.9 
MS4B Method 3 NPS NPS Proteobacteria Altererythrobacter dongtanensis 99.5 
MS4C Method 3 NPS NPS Proteobacteria Erythrobacter sp. 97.7 
MS5A Method 3 NPS NPS Proteobacteria Altererythrobacter sp. 97.8 
MS11E Method 3 NPS NPS Proteobacteria Erythrobacter sp. 99.1 
MS1E Method 1 NPS NPS Bacteroidetes Leeuwenhoekiella sp. 98.9 
MS30 Method 1 NPS NPS Bacteroidetes Maribacter sp. 98.0 
MS1D Method 2 NPS NPS Bacteroidetes Leeuwenhoekiella sp. 99.0 
MS20B Method 2 NPS NPS Bacteroidetes Fluvivirga sp 96.0 
 
aMethod 1: dilution of 1 g of sediment in 9 mL of filtered seawater; Method 2: dilution of 1 g of sediment in 9 mL of filtered seawater followed by incubation in a water 
bath at 60 ºC for 10 min; Method 3: dilution of 5 g of sediment in 15 mL of filtered seawater and incubation with 20 mgL-1 of nalidixic acid and 20 mgL-1 of 
cycloheximide, at 28 °C for 30 min. 
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Figure 5 - Phylogenetic tree of strains belonging to the phylum Actinobacteria, isolated from marine sediments, and their 
GenBank nearest neighbor. Maximum Likelihood phylogenetic tree was performed using 99 sequences with 1112bp and 100 
bootstraps. Bacillus subtilis was used as an outgroup. 32 
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Figure 6 - Phylogenetic tree of strains belonging to the phyla Firmicutes isolated from marine sediments, and their GenBank 
nearest neighbor. Maximum Likelihood phylogenetic tree was performed using 90 sequences with 1045bp and 100 bootstraps 
Escherichia coli was used as an outgroup. 
Bacillaceae 
Paenibacillaceae 
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Figure 7 - Phylogenetic tree of strains belonging to the phyla Proteobacteria, isolated from marine sediments, and their GenBank nearest neighbor. 
Maximum Likelihood phylogenetic tree was performed using 40 sequences with 1365bp and 100 bootstraps. Bacillus subtilis was used as an outgroup. 
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Flavobacteriaceae 
Cytophagaceae 
 
Flammeovirgaceae 
Figure 8 - Phylogenetic tree of strains belonging to the phyla Bacteroidetes, isolated from marine sediments, and their GenBank nearest neighbor. 
Maximum Likelihood phylogenetic tree was performed using 20 sequences with 1237bp and 100 bootstraps. Bacillus subtilis was used as an outgroup. 
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Figure 9- Distribution, in terms of genera, of the isolates recovered from the marine sediment collected on Parque Natural do Litoral Norte, 
according to abundance, treatment methods and selective culture media used. Percentage of isolates belonging to indicated genera within 
the phylum Actinobacteria (A1), Firmicutes (B1), Proteobacteria (C1) and Bacteroidetes (D1); Number of isolates belonging to indicated 
genera recovered according to the culture media used within the phylum Actinobacteria (A2), Firmicutes (B2), Proteobacteria (C2) and 
Bacteroidetes (D2); Number of isolates belonging to indicated genera recovered according to the treatment methods used within the 
phylum Actinobacteria (A3), Firmicutes (B3), Proteobacteria (C3) and Bacteroidetes (D3). 36 
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Figure 10 -Inhibition zones caused in Candida albicans by crude extracts of the strains 
MS8A1 (A), MS18A (B), MS18B (C) MS27A (D), MS29 (E) and MS54 (F).  
The bioactivity potential of all actinobacterial strains isolated in this study was investigated 
by screening crude extracts obtained from these isolates in terms of their antimicrobial 
activity against 5 reference strains - S. aureus, B. subtilis, E. coli, S. typhimurium and C. 
albicans and anticancer activity in the cell lines T47-D breast ductal carcinoma and SH-
SY5Y neuroblastoma. 
The results presented in Table 3 show that crude extracts of 6 isolates belonging to the 
genus Streptomyces (strains MS8A1, MS18A, MS18B, MS27A, MS29 and MS54) exhibit 
antimicrobial activity against C. albicans (Fig. 10). Determination of MIC for these crude 
extracts revealed a biological activity against C. albicans in the range of 125-3.90 μl mL-1, 
with strain MS18B presenting the lowest MIC value (3.90 μl mL-1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the investigation of anticancer activity, the % of cell viability after exposure to 
actinobacterial crude extracts for 24 h and 48 h was measured in two cell lines. The final 
concentration of actinobacterial crude extracts in the MTT assay was 15 µg mL-1. The 
results showed that, after 48 h of exposure, crude extracts of 3 actinobacterial isolates 
presented cytotoxic activity against at least one the cell lines tested. Strains MS3B, MS3E 
and MS56, all belonging to the genus Micromonospora, showed 8%, 5% and 12% of cell 
viability, after 48 h, in the cell lines T47-D or SH-SY5Y. Strain MS18B (Streptomyces sp.) 
was the one that revealed the best results, presenting a % of cell viability <10 for both 
cancer cell lines tested.  
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Table 3 - Antimicrobial and anticancer activities of crude extracts from the actinobacterial isolates obtained in this study 
 
Isolate 
 
Closest identification 
Antimicrobial screening assay 
Anticancer screening assay  
(% of cell viability
a
) 
Disk difusion method MIC (µg mL
-1
) 
S. 
aureus 
B. 
subtilis 
E. coli 
S. 
typhimurium 
C. 
albicans 
C. albicans 
T47-D SH-SY5Y 
24H 48H 24H 48H 
MS3B Micromonospora sp. - - - - - NT ≈104 ≈8 ≈67 ≈90 
MS3C Micromonospora sp. - - - - - NT ≈98 ≈109 ≈95 ≈55 
MS3C1 Micromonospora marina - - - - - NT ≈119 ≈93 ≈98 ≈72 
MS3D1 Streptomyces sp. - - - - - NT ≈73 ≈83 ≈63 ≈62 
MS3E Micromonospora sp. - - - - - NT ≈10 ≈5 ≈9 ≈46 
MS5B Micromonospora sp. - - - - - NT ≈132 ≈96 ≈69 ≈64 
MS5C Micromonospora sp. - - - - - NT ≈82 ≈95 ≈73 ≈96 
MS5D Micromonospora sp. - - - - - NT ≈117 ≈108 ≈107 ≈76 
MS5E 
Micromonospora 
aurantiaca 
- - - - - NT ≈121 ≈99 ≈75 ≈82 
MS8A1 Streptomyces sp. - - - - + 15.62 ≈90 ≈86 ≈86 ≈120 
MS8B Micromonospora sp. - - - - - NT ≈85 ≈92 ≈68 ≈130 
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MS8C Micromonospora sp. - - - - - NT ≈105 ≈71 ≈94 ≈86 
MS14B Streptomyces sp. - - - - - NT ≈127 ≈105 ≈96 ≈81 
MS16B Micromonospora sp. - - - - - NT ≈112 ≈111 ≈86 ≈85 
MS18A Streptomyces sp. - - - - + 15.62 ≈93 ≈88 ≈83 ≈74 
MS18B Streptomyces sp. - - - - + 3.90 ≈20 ≈8 ≈1 ≈2 
MS19 Micromonospora sp. - - - - - NT ≈117 ≈90 ≈85 ≈100 
MS19A Micromonospora sp. - - - - - NT ≈70 ≈98 ≈125 ≈99 
MS19B1 
Micromonospora 
aurantiaca 
- - - - - NT ≈103 ≈98 ≈105 ≈148 
MS19C Micromonospora sp. - - - - - NT ≈107 ≈102 ≈112 ≈71 
MS19D Micromonospora sp. - - - - - NT ≈116 ≈103 ≈89 ≈91 
MS19E Micromonospora sp. - - - - - NT ≈89 ≈103 ≈76 ≈109 
MS19F Micromonospora sp. - - - - - NT ≈121 ≈108 ≈104 ≈80 
MS23A Streptomyces sp. - - - - - NT ≈120 ≈88 ≈104 ≈80 
MS23B Streptomyces sp. - - - - - NT ≈111 ≈104 ≈105 ≈54 
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MS23C Micromonospora sp. - - - - - NT ≈121 ≈114 ≈116 ≈99 
MS23D Micromonospora sp. - - - - - NT ≈33 ≈42 ≈51 ≈93 
MS24 Micromonospora sp. - - - - - NT ≈113 ≈114 ≈104 ≈100 
MS26H Micromonospora sp. - - - - - NT ≈100 ≈104 ≈94 ≈139 
MS26I Micromonospora sp. - - - - - NT ≈86 ≈120 ≈109 ≈140 
MS27A Streptomyces sp. - - - - + 62.5 ≈114 ≈69 ≈75 ≈56 
MS29 Streptomyces sp. - - - - + 15.62 ≈84 ≈76 ≈100 ≈108 
MS32 Streptomyces sp. - - - - - NT ≈74 ≈98 ≈91 ≈121 
MS35 Nocardiopsis sp. - - - - - NT ≈108 ≈112 ≈99 ≈120 
MS38 Herbiconiux solani - - - - - NT ≈102 ≈89 ≈84 ≈85 
MS39B Arthrobacter sp - - - - - NT ≈125 ≈99 ≈106 ≈74 
MS39C Arthrobacter sp - - - - - NT ≈121 ≈103 ≈107 ≈87 
MS40A Arthrobacter sp - - - - - NT ≈112 ≈92 ≈100 ≈160 
MS40B1 Arthrobacter sp - - - - - NT ≈97 ≈112 ≈95 ≈115 
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MS42 
Micromonospora 
aurantiaca 
- - - - - NT ≈116 ≈94 ≈114 ≈88 
MS46 Micromonospora peucetia - - - - - NT ≈115 ≈109 ≈113 ≈65 
MS48 Micromonospora sp. - - - - - NT ≈107 ≈100 ≈105 ≈98 
MS49 Micromonospora sp. - - - - - NT ≈84 ≈49 ≈68 ≈136 
MS50 Micromonospora sp. - - - - - NT ≈108 ≈74 ≈84 ≈160 
MS51 Micromonospora sp. - - - - - NT ≈97 ≈51 ≈106 ≈147 
MS52A Micromonospora maritima - - - - - NT ≈63 ≈99 ≈53 ≈98 
MS52B Micromonospora marina - - - - - NT ≈67 ≈93 ≈69 ≈152 
MS53 Polymorphospora rubra - - - - - NT ≈82 ≈96 ≈101 ≈125 
MS54 Streptomyces sp. - - - - + 125 ≈99 ≈100 ≈115 ≈71 
MS55 
Micromonospora 
aurantiaca 
- - - - - NT ≈83 ≈74 ≈60 ≈103 
MS56 
Micromonospora 
aurantiaca 
- - - - - NT ≈69 ≈68 ≈45 ≈12 
MS58 Actinomadura sputi - - - - - NT ≈84 ≈95 ≈71 ≈125 
Legend: -, no inhibition; +, growth inhibition; NT, not tested 
a Cell viability was assessed using the MTT assay  
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 Discussion 
The marine environment is a promising source of new microorganisms with potential to 
produce bioactive compounds. The Portuguese coast is largely unexplored in terms of 
microbial diversity, and this includes actinobacteria (Prieto-Davó., 2016).   
In this study, the actinobacteria associated with marine sediment collected on a beach in 
Parque Natural do Litoral Norte, in Portugal, was investigated through cultivation-
dependent methods. A total of 117 isolates were obtained, of which 52 were identified as 
actinobacteria. The marine sediment revealed to be rich in terms of actinobacterial 
diversity, being identified 7 different genera, with the largest fraction of these isolates 
belonging to the genus Micromonospora. The actinobacterial genera recovered from the 
studied sediment have been reported before in studies with other marine sediments. 
Prieto-Davó et al. (2016) identified a total of 24 actinobacterial genera in marine sediments 
collected around the Madeira archipelago, and concluded that the genera Streptomyces, 
Actinomadura and Micromonospora were the most abundant. Other authors indicate that 
actinobacteria belonging to the family Micromonosporaceae are amongst the most 
dominant bacteria in marine sediments (Gontang et al., 2007; Jensen et al., 1991; 
Weyland, 1969). Sediments collected in the North Sea and Chesapeake Bay were found 
to be rich in Streptomyces, Nocardia, Micromonospora and Microbispora species 
(Weyland, 1969, 1984; Takizawa et al., 1993). The genera Micromonospora and 
Streptomyces have been found to be the most dominant in sediments collected from 
Trondheim Fjord, Norway (Bredholt et al., 2008) and Duncan et al. (2014, 2015) showed 
that the genera Micromonospora, Nocardia, Nocardiopsis, Pseudonocardia and 
Streptomyces were predominant in marine sediments sampled in New Brunswick, 
Canada.  
The three treatment methods used in this study for processing the marine sediment 
sample were applied in order to inhibit the growth of irrelevant microorganisms and to 
promote spore germination of actinobacterial strains. These methods have been 
successfully used by several authors for the isolation of actinobacteria. Xiong et al. (2015) 
employed 7 different pretreatments, including incubation at 60 ºC for 10 min (method 2 in 
this study) and incubation with nalidixic acid and cycloheximide at 28 °C for 30 min 
(method 3 in this study) for the isolation of actinobacteria from marine sediments collected 
from the Yellow Sea. By using as selective media ABSM4 agar, ISP3 and humic acid-
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vitamin agar (HVA), the authors were able to isolate 613 actinobacterial strains of which 
the genera Streptomyces, Micromonospora, Kocuria, Nocardiopsis and 
Saccharomonospora were found to be the most bioactive ones. Abdelfattah et al. (2016) 
was able to recover bioactive Streptomyces and Nocardiopsis species from marine 
sediments collected from the Red Sea coast by incubating the samples in a water bath at 
60 ºC for 10 min (method 2 in this study) and using the selective media HVA and SCN. 
The isolation of actinobacteria from various marine sources has been shown to be more 
efficient when using culture media with low nutrient concentrations, which better simulate 
the marine environment and avoid the development of fast-growing microorganisms 
(Gontang et al., 2007; Hames-Kocabas & Uzel, 2012; Jensen et al., 2005). This is the 
case of the NPS medium used in the present study, which was formulated only with 
nutrients obtained from the same habitat of the isolated microorganisms. Jensen et al. 
(2005) used this medium to recover from a marine sediment collected in the island of 
Guam a high number of salt-dependent actinobacterial isolates belonging to 
Micromonospora, Streptomyces and Actinomadura genera. Gotang et al. (2007) used an 
oligotrophic medium, similar to NPS medium, consisting only of sea water and agar to 
cultivate Gram-positive bacteria from sediments collected in the Republic of Palau from the 
intertidal zone, 70% (of a total of 199 strains) of the obtained isolates were recovered from 
this medium, all of them belonging to the genera Actinobacteria and Firmicutes. 
The selective media SCN and M3 have been also successfully used for the isolation of 
actinobacteria, though in this study SCN only allowed the isolation of a small fraction of 
actinobacterial strains and M3 did not retrieve any isolate. Maldonado et al (2005) 
employed 6 selective culture media, including M3 and SCN, for the isolation of 
actinobacteria from marine sediments collected in different locations (Japan Trench, 
Canary Basin and Norway fjords) (Maldonado el al., 2005), and, contrary to the results of 
the present study, they were able to obtain a large number of isolates in the M3 and SCN 
media. Overall, the authors obtained isolates belonging to the genera Actinomadura, 
Dietzia, Gordonia, Microbacterium, Mycobacterium, Nocardiopsis, Pseudonocardia, 
Saccharopolyspora, Streptosporangium, Nonomuraea, Verrucosispora and Williamsia.  
The treatment methods and the selective media used in this study also allowed the 
isolation of microbial genera, other than actinobacteria. These microbial genera were 
found to belong to the phyla Firmicutes (2 genera identified), Proteobacteria (4 genera 
identified) and Bacteroides (3 genera identified). The phylum Firmicutes includes Gram-
positive bacteria, with some members of this group being spore-forming, like the Bacillus 
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and Paenibacillus strains recovered in this study, which may explain their resistance to the 
used treatment methods. The antibiotics used for the isolation of actinobacteria, nalidixic 
acid and streptomycin, have a broad spectrum against Gram-negative bacteria, but the 
results obtained indicate that the Proteobacteria and Bacteroidetes isolates recovered in 
this study are resistant to these antibiotics. As these isolates are not known to produce 
spores, it is remarkable that some of them could resist to 10 min of incubation at 60 ºC.  
Marine actinobacteria are a recognized source of bioactive compounds (Duncan et al., 
2015; Hassan & Shaikh, 2017). In this study, all actinobacterial isolates obtained were 
screened for their antimicrobial and anticancer activities. Antimicrobial assays showed that 
crude extracts of 6 isolates (strains MS8A1, MS18A, MS18B, MS27A, MS29 and MS54) 
belonging to the genus Streptomyces exhibited activity against C. albicans. This is not a 
surprising result as members of the genus Streptomyces are the major producers of 
bioactive secondary metabolites within the phylum Actinobacteria (Berdy, 2005;2012; 
Hassan & Shaikh, 2017). A number of secondary metabolites produced by Streptomyces 
species is derived from strains isolated from marine sediments and, regarding 
antimicrobial activity, these microorganisms exhibit more frequently activities against fungi 
and Gram-positive bacteria than against Gram-negative bacteria (Bredholt et al., 2008; 
Duncan et al., 2015; Duncan et al., 2014; Hassan & Shaikh, 2017; Nakashima et al., 2009; 
Xiong et al., 2015). Examples of some secondary metabolites produced by marine 
Streptomyces with antifungal activity against C. albicans include isoikarugamycin, a new 
polycyclic tetramic acid macrolactam that is effective at a MIC value of 2-4 μg mL-1 (Lacret 
et al., 2014), daryamides A and B, exhibiting MIC values of 62.5 and 125 μg mL-1, 
respectively (Asolkar et al., 2006; Mitchell et al., 2004), 4-phenyl-1-napthyl-phenyl 
acetamide, which has a strong antifungal activity particularly against C. albicans 
(Dhanasekaran et al., 2008). The comparison of the MIC values of the cited compounds 
with the ones obtained in this study (values in the range of 125-3.90 μg mL-1), suggest that 
the crude extracts of the isolated Streptomyces strains may have a high bioactivity 
potential, especially given the fact that these MIC values were tested with crude extracts 
and not with pure compounds, as is the case of the compounds indicated above. In the 
future, it will be important to investigate if new secondary metabolites may be present in 
these extracts.  
Screening of anticancer activity showed that crude extracts (tested at a concentration of 15 
µg mL-1) of strains MS3B, MS3E and MS56 belonging to the genus Micromonospora, and 
MS18B, identified as a Streptomyces sp., had promising anticancer activities. After an 
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incubation period of 48 h, crude extracts of strains MS3B, MS3E and MS56 led to a cell 
viability of 8% and 5% in the cell line T47-D, and 12% in the cell line SH-SY5Y, 
respectively, while strain MS18B induced cell viabilities of, respectively, 8% and 2% in the 
two cancer cell lines tested. Micromonospora species isolated from marine sediments are 
known to produce diverse anticancer compounds, such as diazepinomycin, an alkaloid 
compound with high antitumor activity, lagumycin B, an angucycline antibiotic with 
cytotoxicity against diverse cancerous and non-cancerous cell lines and streptonigrin, a 
natural compound with potent activity against human neuroblastoma SH-SY5Y cell line 
(McAlpine et al., 2008; Mullowney et al., 2015; Wang et al., 2002) A vast number of 
secondary metabolites with anticancer activity has been described for Streptomyces 
strains isolated from marine sediments, such as daryamides, with moderate cytotoxicity 
against human colon carcinoma cell line, and aureoverticillactam and chromomycin B, 
which exhibit high cytotoxic activity against several tumor cell lines (Asolkar et al., 2006; 
Lu et al., 2012; Mitchell et al., 2004). 
As with the crude extracts that showed antimicrobial activity, in the future it will be 
important to better assess the anticancer activity of the most promising extracts and to 
investigate if new anticancer compounds may be responsible for these activities. To the 
best of our knowledge this is the first study on the isolation of actinobacteria from marine 
sediment of the Portuguese northern coast and investigation of their bioactive potential, 
namely antimicrobial and anticancer.  
 Conclusion 
This study focused on the isolation of actinobacteria from marine sediment of the 
Portuguese northern coast and on the screening of their potential to produce bioactive 
compounds. In total, 117 isolates were recovered, of which 52 strains were identified as 
actinobacteria. The marine sediment showed to have a high diversity of actinobacteria, 
having been identified 7 different genera, with the majority of the isolates belonging to the 
genus Micromonospora. Results revealed that the three treatment methods and culture 
media used in this study allowed the recovery of isolates belonging to the genera 
Micromonospora, Streptomyces, Arthrobacter, Polymorphospora, Herbiconiux, 
Nocardiopsis and Actinomadura. Most actinobacterial isolates were recovered from NPS 
medium, indicating that isolation of these microorganisms is more effective when using 
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nutrient-poor culture media that better mimics the marine environment. Only a small 
fraction of actinobacterial isolates could be recovered from SCN medium, while no growth 
was obtained in M3 medium. Besides actinobacterial isolates, the treatment methods and 
selective culture media used in this study also allowed the isolation of bacterial genera 
belonging to the phyla Firmicutes, Proteobacteria and Bacteroides.  
Crude extracts of strains MS8A1, MS18A, MS18B, MS27A, MS29 and MS54 belonging to 
the Streptomyces genus showed activity against C. albicans. MIC values obtained (in the 
range of 125 - 3.90 μg mL-1) show that crude extracts resultant from these Streptomyces 
isolates may have a high bioactive potential, being now necessary to investigate the 
presence of new bioactive molecules in these extracts. These results confirm the 
remarkable capacity of Streptomyces species to produce bioactive compounds. 
Screening of anticancer activity showed that crude extracts of strains MS3B, MS3E and 
MS56 belonging to the genus Micromonospora, and MS18B, identified as Streptomyces 
sp., had promising anticancer activities, especially strain MS18B which presented cell 
viability values lower than 10% in the two cell lines tested. In the future, it will be important 
to better investigate the antimicrobial and anticancer activities of the crude extracts of the 
most promising strains and the possible presence of new compounds. 
The results obtained in this study will contribute to increase the scant information available 
on culturable actinobacteria associated with marine sediments of the Portuguese coast 
and of their bioactive potential.  
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CHAPTER 3  
ISOLATION AND INDENTIFICATION OF RARE 
ACTINOBACTERIA FROM THE MARINE SPONGE 
H.PERLEVIS 
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 Introduction 
The excessive and undue use of antibiotics is leading to an increase in multidrug-resistant 
bacterial infections, for which new therapeutic alternatives are clearly needed. In addition, 
there is an enormous need to find effective and less aggressive treatments against many 
serious diseases, such as cancer (Duncan et al., 2015). These problems demand an 
urgent search for new treatment strategies and the discovery of new natural compounds 
with relevant pharmacological activities is an important route to achieve this goal 
(Abdelmohsen et al., 2010b; Undabarrena et al., 2016). 
The phylum Actinobacteria, and especially the class Actinobacteria, is well known for its 
great capacity to produce secondary metabolites with a wide range of bioactivities, many 
of these compounds having a significant role in human health. Among these 
microorganisms, members of the genus Streptomyces are considered the major producers 
of relevant bioactive compounds, being responsible for the production of more than 10 400 
bioactive metabolites (Berdy, 2012).  Due to their outstanding biosynthetic potential, 
Streptomyces species have been extensively explored in the last decades, which has 
resulted in a marked decrease in the discovery of new compounds from these 
microorganisms (Berdy, 2005). In order to increase the discovery rate of new bioactive 
compounds, it is important to focus the research in other actinobacterial genera, mainly in 
rare genera of actinobacteria, since the biosynthetic potential of these microorganisms is 
underexplored (Subramani & Aalbersberg, 2013). 
The term rare actinobacteria usually refers to non-Streptomyces species or to 
actinobacterial strains that are isolated less frequently using conventional culture-
dependent methods (Berdy, 2005; Dhakal et al., 2017). In the recent decades, through the 
employment of isolation approaches that favor the enrichment of rare actinobacteria, a 
high diversity of these microorganisms has been reported in the literature. These 
microorganisms are responsible for the production of more than 3000 different bioactive 
metabolites (Berdy, 2005;2012; Tiwari & Gupta, 2013). Examples include 
pseudonocardians, dermacozines, marinacarbolines, neomaclafungin, etc., produced by 
microorganisms belonging to the genera Pseudonocardia, Dermacoccus Marinactinospora 
and Actinoalloteichus and exhibiting various bioactivities such as antibacterial, cytotoxic, 
antioxidant, antimalarial and antifungal, being (Abdel-Mageed et al., 2010; Huang et al., 
2011; Li et al., 2011; Sato et al., 2012). 
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Unexplored or underexplored habitats, such as marine ecosystems, are considered major 
sources of rare actinobacteria and of new bioactive compounds with biotechnological 
importance (Dhakal et al., 2017).  
Marine sponges belong to the phylum Porifera are one of the oldest multicellular living 
beings in the world. These sessile and filtering organisms are known to develop various 
symbiosis relationships with bacteria, and these associations are so important that 
microbial abundance in sponges may account up to half of their weight (Abdelmohsen et 
al., 2010a). Marine sponges are a known source of biologically active metabolites, but in 
some cases the production is carried out by their microbial symbionts rather than by the 
sponge itself (Wilson et al., 2014). These organisms have been described to host a wide 
variety of actinobacteria, many of them being rare and new (Abdelmohsen et al., 2014). 
Examples of rare actinobacteria isolated from marine sponges include species of 
Nocardiopsis, Actinomadura, Salinispora and Verrucosispora, and many of them were 
shown to be capable of producing secondary metabolites with antimicrobial and cytotoxic 
activities, like nocapyrones, bendigoles, rifamycins and thiocoraline (Kim et al., 2006; 
Schneemann et al., 2010; Simmons et al., 2011; Wyche et al., 2011). 
This study had as objective the isolation and identification of rare actinobacteria 
associated with the marine sponge Hymeniacidon perlevis, collected in the intertidal zone 
of a beach in northern Portugal. This species of sponge is distributed along the Atlantic 
Ocean, Mediterranean coast and the Yellow Sea, and usually colonizes rocks or other 
hard surfaces buried in marine sediments (Alex et al., 2013). Previous studies have shown 
a large diversity of actinobacteria in samples of H. perlevis obtained from the Yellow Sea 
South China Sea and Atlantic Ocean (Alex et al., 2013; Sun et al., 2010; Xi et al., 2012; 
Xin et al., 2008; Xin et al., 2009; Zhang et al., 2006), however, to the best of our 
knowledge, rare actinobacteria associated with this sponge inhabiting the Portuguese 
coast has never been investigated before.   
 Materials and Methods 
 Sample collection  
The sponge H. perlevis was collected in the intertidal zone of Memória beach, in 
Matosinhos, Portugal (41°13.840157'N, 8°43.331863'W). The sponge was transferred to a 
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sterile plastic bag, transported to the laboratory in a cooling box and processed within an 
interval of two hours. 
The sponge was identified by an experienced researcher as belonging to the species 
Hymeniacidon perlevis, through the analysis of its morphological characteristics. 
 Isolation of rare actinobacteria 
The sponge was initially washed, under sterile conditions, with sterile marine water to 
remove looser particles. Three fragments with ca. 1.5 g each were then cut, weighted and 
homogenized separately in a sterile mortar with 2 mL of sterile seawater. Each macerated 
fragment was then subjected to one of the following pretreatments: incubation in a 
microwave (2450 MHz) for 3 min at 120 W (pretreatment 1); incubation in a water bath at 
60 ºC for 30 min (pretreatment 2) and incubation in an oven at 120 °C for 60 minutes 
(pretreatment 3). The resulting samples were then ten-fold diluted to 10-4 and an aliquot of 
100 µl of each dilution was spread over the surface of the following selective isolation 
media: M1 agar (per liter of seawater): 10 g of soluble starch, 4 g of yeast extract, 2 g of 
peptone and 17 g of agar; M2 agar (per liter, with a ratio of seawater:deionized water of 
90:10): 6 mL of glycerol, 1 g of arginine, 1 g of K2HPO4, 0.5 g of MgSO4 and 18 g of agar; 
Starch-casein-nitrate agar (SNC) (per liter, with a ratio of seawater:deionized water of 
60:40): 10 g of soluble starch, 0.3 g of casein, 2 g of K2HPO4, 2 g of KNO3, 2 g of NaCl, 
0.05 g of MgSO4.7H2O, 0.02 g of CaCO3, 0.01 g of FeSO4.7H20 and 17 g of agar. All 
media were supplemented with cycloheximide (50 mgL-1), acid nalidixic (50 mgL-1) and 
nystatin (50 mgL-1) in order to inhibit the growth of fungi and Gram-negative bacteria. The 
plates were incubated at 28 °C for a period of 4 months.  
Along the incubation period, plates were periodically inspected by visual observation and 
all colonies with different morphological characteristics were picked and re-streaked 
numerous times in the same agar medium until obtainment of pure colonies. Each isolate 
was cryopreserved at -80 ºC in 30% glycerol. Before the cryopreservation step each 
isolate was grown in 5 mL of liquid medium, M1, M2 or SCN, according to the respective 
isolation medium, at 25 ºC, 100 rpm, for one week and 1 mL of grown culture was used for 
cryopreservation. 
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 Identification of isolated strains by 16S rRNA gene sequencing 
Genomic DNA was extracted from all isolated microorganisms using the E.Z.N.A.® 
Bacterial DNA Kit, (Omega Biotek, Norcross, GA), following the manufacturer's 
instructions, with a few modification steps: (i) before starting the extraction protocol, 
samples were incubated at 95 °C for 10 min, followed by incubation on ice for more 10 
min; (ii) in the step of lysozyme addition, the samples were incubated at 37 °C for 30 min, 
instead of 10 min as mentioned in the kit protocol; (iii) in the optional step used for bacteria 
difficult to lyse, two Zirconia beads (2.3 mm diameter) were added along with the glass 
beads and the samples were vortexed for 10 min; (iv) incubation with proteinase K was 
made with a concentrated stock (10 mg mL-1) instead of the solution provided in the kit and 
was extended up to 2h (v) the centrifugation speeds described in the kit protocol were 
increased in all steps from 10,000 g to 13,000 g; (vi) in the final step of DNA elution, 25 μL 
of elution buffer were added to the HiBind® DNA Mini Column, instead of 50-100 μL as 
indicated in the protocol (step performed twice). 
Biomass for DNA extraction was obtained through centrifugation of 2 ml of the liquid 
cultures (7.000 g for 5 min) previously grown for cryopreservation purposes. 16S rRNA 
gene was amplified by PCR using the universal primers 27F (5'-
GAGTTTGATCCTGGCTCAG-3') and 1492R (5'-TACGGYTACCTTGTTACGACTT-3') 
(Lane, 1991). The PCR mixture (total volume of 10 μL) contained: 5 μL of Taq PCR Master 
Mix (Qiagen, Valencia, CA), 1 μL of primer 27F (2 µM), 1 μL of primer 1492R (2 µM) and 3 
μL of DNA template. Negative controls were also conducted and consisted in replacing in 
the PCR mixture the DNA template by 3 μL of Nuclease-Free Water. PCR conditions were 
as following: initial denaturation at 95 °C for 15 min, followed by 30 cycles at 94 °C for 30 
s, 48 °C for 90 s, 72 °C for 90 s and a final extension at 72 °C for 10 min. PCR was 
performed in an Applied Biosystems ThermoCycler (Applied Biosystems Inc., Foster City, 
CA, USA). PCR products were separated on a 1.5% agarose gel containing SYBR Safe 
(ThermoFisher Scientific, USA), at 150 V for 30 min. Purification and sequencing of the 
amplified DNA was performed by GenCore, I3S (Instituto de Investigação e Inovação em 
Saúde, Portugal). The obtained 16S rRNA sequences were analyzed using the Geneious 
software, version 4.8.2 and the resulting consensus sequences were compared to the 
GenBank database using the blastn algorithm. The consensus sequences were 
additionally compared with the databases EzTaxon (http://www.ezbiocloud.net/) and 
52 
 
Ribosomal Database Project (https://rdp.cme.msu.edu/index.jsp) in order to confirm the 
results obtained in the GenBank database.  
All the sequences and their five closest neighbor sequences in Genbank were aligned 
using the Geneious software. The alignment was used to generate a Maximum Likelihood 
phylogenetic tree of 1366bp, performed as the defaults of the ATCG South of France 
bioinformatics platform (http://www.atgc-montpellier.fr/) with 100 bootstraps. 
 Results  
The isolation of rare actinobacteria from the marine sponge, H. perlevis, was performed 
using three different pretreatments and three selective culture media. Along an incubation 
period of 4 months, a total of 188 isolates with distinct morphological characteristics were 
obtained. Most of the colonies grown in the culture media exhibited morphological 
characteristics typical of actinobacteria, such as presence of spores or hyphae, colonies 
with a leather texture and with diverse colors and alteration of the color of the media. 
Figure 11, shows examples of some of the colonies isolated. 
 
 
Figure 11 - Examples of some isolates obtained from H. perlevis. (A) Strain E101, (B) strain E172, (C) strain 
E230, (D) strain E69, (E) strain E102, (F) strain E207, (G) strain E209 and (H) strain E221. 
 
The distribution of the number of recovered isolates according to the pretreatments and 
culture media employed is presented in Fig. 12. By analysing this figure it is possible to 
observe that the pretreatment that allowed a higher recovery of isolates was pretreatment 
1 (microwave incubation), with 125 isolates being obtained. Pretreatment 2 (incubation at 
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60 ºC) led to the isolation of 61 different colonies, while incubation at 120 ºC was shown to 
be highly selective, only allowing the recovery of 2 isolates. The selective media employed 
led to a more or less even distribution of the recovered isolates, though medium M1 
always had a sligthly higher number of isolates. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 12 - Number of isolates recovered according to the pretreatments and culture media used in this study 
for the isolation of rare actinobacteria from the marine sponge H. perlevis. 
 
For taxonomical identification of the obtained isolates the nearly full-length (>1300 bp) 16S 
rRNA gene was sequenced. To date, it has only been possible to identify 18 isolates, of 
which 17 were found to belong to the phylum Actinobacteria and only one was identified as 
belonging to the phylum Firmicutes (Table 4 and Fig 13). The identification results of these 
isolates also revealed that the 17 actinobacterial strains identified so far have a high 
phylogenetic diverstiy, belonging to 5 different families (Streptomycetaceae, 
Nocardiopsaceae, Tsukamurellaceae, Brevibacteriaceae and Nocardiopsaceae) and 6 
genera (Streptomyces, Nocardia, Gordonia, Tsukamurella, Brevibacterium and 
Nocardiopsis). Interestingly , with the exception of the genus Streptomyces, all the other 
genera constitute rare actinobacterial genera. 
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    Table 4 - Taxonomic identification of some isolates obtained from the marine sponge H. perlevis 
Isolate Pretreatment Culture medium Phylum Identification Similarity % 
E67 Microwave M2 Actinobacteria Nocardia sp. 99.0 
E74 Microwave M2 Actinobacteria Streptomyces sp. 99.8 
E79 Microwave M2 Actinobacteria Nocardiopsis prasina 99.8 
E82 Microwave M2 Actinobacteria Streptomyces sp. 100 
E85 Microwave M2 Actinobacteria Streptomyces sp. 99.8 
E87 Microwave M2 Actinobacteria Brevibacterium sp. 98.9 
E194 Microwave M2 Actinobacteria Nocardia sp. 99.0 
E229 Microwave M2 Actinobacteria Streptomyces thermocarboxydus 99.8 
E247 Microwave M2 Actinobacteria Streptomyces sp. 100 
E99 Microwave SCN Actinobacteria Streptomyces sp. 100 
E107 Microwave SCN Actinobacteria Streptomyces sp, 100 
E109 Microwave SCN Actinobacteria Gordonia sp. 99.0 
E117 Microwave SCN Actinobacteria Tsukamurella sp. 99.3 
E119 Microwave SCN Actinobacteria Streptomyces sp 99.9 
E122 Microwave SCN Actinobacteria Streptomyces niveus 99.6 
E171 Incubation 60ºC SCN Actinobacteria Streptomyces sp. 100 
E199 Incubation 60ºC SCN Firmicutes Bacillus licheniformis 99.1 
E202 Incubation 60ºC SCN Actinobacteria Streptomyces sp. 100 
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Nocardiaceae 
Figure 13 - Phylogenetic tree of identified actionobacterial strains isolated from sponge H. perlevis and their GenBank nearest neighbor. Maximum Likelihood phylogenetic tree 
was performed using 79 sequences with 1366bp and 100 bootstraps. Bacillus subtilis was used as an out group. 
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 Discussion 
 
Different pretreatments and selective culture media are usually employed for the isolation 
of rare actinobacteria (Subramani & Aalbersberg, 2013). In this study, the pretreatments 
used for the isolation of rare actinobacteria from the marine sponge, H. perlevis, showed to 
have a high influence in the number of retrieved isolates, with microwave incubation 
allowing the isolation of the largest number of different colonies. Several studies have 
demonstrated that microwave irradiation promotes the isolation of rare actinobacteria, 
such as Micromonospora, Micropolyspora, Nocardia, Actinomadura, Streptosporangium 
and Lentzea sp. (Bulina et al. 1997; Yang et al. 2008; Xue et al. 2010; Wang et al. 2013). 
Nonethless, some of these studies have also showed that this pretreatment could increase 
as well the isolation of Streptomyces sp. In the present study, microwave irradiation 
(pretreatment 1) led to the isolation of Nocardia, Gordonia, Tsukamurella, Nocardiopsis 
and Brevibacterium sp., which are considered rare actinobacterial genera, but also 
Streptomyces sp., which is in accordance with previous studies. 
The application of pretreatments consisting in the heating of samples are described in the 
literature to be selective for the isolation of sporulating bacteria, having also shown 
efficient for the isolation of rare actinobacteria (Jiang et al., 2016). Imada et al. (2010) 
incubated samples of marine sediments at 55 ºC for 30 min and was able to isolate 
microorganisms belonging to the genera Micromonospora and Streptomyces. Jiang et al. 
(2016) reported that the incubation of samples of water or soil suspensions at 60 ºC for 30 
min was effective in the isolation of Micromonospora sp. Eccleston et al. (2008) was able 
to select several genera of the family Micromonosporae by combining different 
pretreatments, one of which consisting in the incubation of samples of aquatic sediments, 
at 55 ºC for periods of 30 or 60 min. In this study, incubation of a sample of H. perlevis at 
60 ºC for 30 min resulted, until the moment, in the isolation of bacterial strains belonging to 
the genus Streptomyces, which is not a surprising result due to the fact that these 
microorganisms produce spores that may withstand this temperature. However, as only 3 
strains retrieved from this pre-treatment have been identified so far, it is not possible to 
conclude on the efficacy of this treatment on the isolation of rare actinobacteria.  
Incubation of a sample of H. perlevis at 120 ºC for 60 min (pretreatment 3) was shown to 
be extremely selective in terms of recovery of different isolates. This treatment was applied 
in this study with the objective of eliminating spores of Streptomyces species as these 
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microorganisms usually have a faster growth when compared with rare actinobacteria 
genera, and may thus prevent their growth (Hayakawa et al., 1991; Nonomura, 1969). This 
pre-treatment has been demonstrated before to be a good approach for the isolation of 
rare actinobacteria, such as Streptosporangium sp., once the sporangiospores that these 
species produce are capable of withstanding and resisting harsh physical and chemical 
pretreatments (Hayakawa et al., 1991). Similarly, conidia producing species, such as 
Dactylosporangium sp. have also shown to have a high survival rate when exposed to this 
pre-treatment, with 140 species of this genus having been isolated by applying this 
pretreatment (Hayakawa et al., 1991). In another study, Niyomvong et al. (2012) showed 
that combining different pretreatments, such as incubation in a water bath at 50 °C for 6 
min, followed by dry incubation at 120 °C for 1 h and addition of 1.5% phenol, resulted in a 
lower recovery of non-target bacteria and increased the isolation of rare actinobacteria 
belonging to the genera Actinoplanes, Gordonia, Microbiospora, Micromonospora, 
Nocardia and Nonomuraea. Though the isolates retrieved from pre-treatment 3 have not 
yet been identified, according to the literature, there are good chances that these isolates 
belong to rare actinobacteria genera, and they may be very promising for the production of 
bioactive compounds. 
Regarding the extraction of DNA from the various isolates, the use of an optimized 
protocol proved to be more efficient, as it was possible to obtain a higher quantity of 
extracted DNA. Sequencing of the 16S rRNA gene is widely used in phylogenetic studies 
since this region of DNA is characteristically well conserved in different bacterial species, 
having at the same time several zones with specific polymorphisms that allow an adequate 
evaluation of the phylogenetic relationships between bacteria. Phylogenetic analyses of 
the isolates so far identified revealed that 11 isolates are Streptomyces sp., having been 
obtained from pretreatments 1 and 2. Although not considered rare actinobacteria, this 
genus is the largest producer of bioactive compounds belonging to the phylum 
Actinobacteria, so it will always be important to test in the future the antimicrobial and 
anticancer activities associated with these isolates (Dhakal et al., 2017; Hassan & Shaikh, 
2017). Nonetheless, the fact that these microorganisms have been intensively explored 
reduces the probability of finding new bioactive compounds. Taxonomic results also 
showed that some isolates obtained from the sponge H. perlevis, belonged to rare 
actinobacteria genera, namely to the genera Nocardia, Gordonia, Tsukamurella, 
Brevibacterium and Nocardiopsis, indicating that the experimental approach used in this 
study seems to be suitable for the selection of rare actinobacteria. 
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The actinobacterial community associated with the sponge H. perlevis inhabiting the 
Yellow sea and the South China Sea has been studied before by some authors (Sun et al. 
(2010), Xi et al. (2012), Xin et al. (2009) and Zang et al. (2006). Similarly, to the present 
study, the authors used different selective culture media but no pretreatments were 
applied, except in the study of Xi et al. (2012), where the samples were incubated in a 
water bath at 55 °C for 6 min. In these studies, several actinobacterial genera associated 
with H. perlevis were isolated, namely Streptomyces, Nocardiopsis, Gordonia, Nocardia, 
Micromonospora, Pseudonocardia, Salinispora, Mycobacterium and Rhodococcus, with 
the first 4 genera being also identified in the present study. Sun et al. (2010) used in their 
study seven different selective culture media, including the M1 and M2 media also used in 
this study. In contrast to our results, the authors reported that the medium allowing the 
greatest diversity and largest number of actinobacteria was M2, while the medium M1 did 
not led the isolation of colonies with specific characteristics of actinobacteria.In the study 
conducted by Zhang et al. (2006), eight selective culture media were used, also including 
the M1 and M2 media. Medium M1 led to the isolation of microorganisms belonging to 4 
different genera: Streptomyces, Nocardiopsis, Nocardia and Micromonospora, while M2 
retrieved isolates belonging to 7 actinobacterial genera: Rhodococcus, Micromonospora, 
Nocardia, Pseudonocardia, Nocardiopsis and Streptomyces.  
In order to conclude the present study, the remaining isolates will be identified and the 
bioactive potential, namely antimicrobial and anticancer activities, of all isolates identified 
as actinobacterial species will be investigated. 
 Conclusion 
This study focused on the isolation and identification of rare actinobacteria from the marine 
sponge H. perlevis. Of the 188 strains isolated from this sponge, only 18 were possible to 
be taxonomically identified, revealing the isolation of rare genera of actinobacteria, such as 
Nocardia, Nocardiopsis, Brevibacterium, Gordonia and Tsukamurella, which are quite 
promising regarding the production of bioactive compounds. Results revealed that the 
three pretreatments applied for maximizing the chances of isolating rare actinobacteria 
had a high influence in the number of recovered isolates and that microwave incubation 
was the pretreatment that led to the largest diversity of microbial colonies. This pre-
treatment allowed the isolation of the actinobacterial genera previously indicated, and also 
Streptomyces sp. Though this last genus is not considered rare, due to its prolific capacity 
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to produce bioactive compounds, it will be always interesting to investigate the bioactive 
potential of the Streptomyces strains obtained in this study. Incubation of H. perlevis at 60 
ºC resulted, so far, in the isolation of Streptomyces sp., however the majority of the 
microbial strains retrieved from this pre-treatment has not been identified yet, and so the 
results obtained do not allow drawing consistent conclusions on the efficacy of this pre-
treatment to isolate rare actinobacteria. Incubation of H. perlevis at 120 ºC has shown to 
be very selective, only leading to the isolation of two different colonies but, according to 
the literature, there are high chances of these isolates being rare actinobacteria. 
As future work, it will be necessary to identify the remaining isolates and to test their ability 
to produce compounds with antimicrobial and anticancer activity. 
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CHAPTER 4 
GENERAL DISCUSSION AND CONCLUSIONS 
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 General discussion 
Natural compounds are the most important resources for the discovery of new drugs, such 
as antibiotics to combat resistant bacteria and anticancer agents to combat cancer.  A 
large fraction of the drugs commercially available in the last decades has a natural origin 
or is inspired in natural molecules. Bacteria are at the top of the organisms producing 
natural compounds, with the phylum Actinobacteria being the most renowned one in the 
production of secondary metabolites with various important bioactivities at the 
pharmaceutical and industrial level.  The genus Streptomyces is the most known due to its 
wide capacity to produce bioactive compounds with different bioactivities, however rare 
actinobacteria have been also demonstrated to be important contributors for the 
production of bioactive compounds. 
Due to the overexploitation of terrestrial environments, a great interest has arisen in recent 
years in the prospection of microorganisms from marine environments and, in this context, 
marine actinobacteria have already shown to be an important source of bioactive 
compounds. In this thesis, two different marine samples, coastal marine sediment and a 
marine sponge, both collected in the coastal area of northern Portugal, were explored in 
terms of cultivable actinobacteria in order to assess their potential to produce bioactive 
compounds with antimicrobial and anticancer activity. The Portuguese coast is largely 
unexplored regarding microbial diversity, including actinobacteria, and their bioactive 
potential. The results of the first study conducted in this thesis revealed that the marine 
sediment collected on a beach on Parque Natural do Litoral Norte presented a high 
diversity of actinobacteria and that some of these isolates had a promising antimicrobial 
and anticancer potential, as shown by the results obtained with crude extracts of some 
isolates belonging to the genera Streptomyces and Micromonospora. These results are 
very interesting, being now important to analyze these crude extracts in order to 
investigate the potential presence of new bioactive substances. In addition, the results 
obtained in this study indicate that more efforts should be undertaken to bioprospect other 
marine sediments from the Portuguese coast. The second study presented in this thesis 
focused on the isolation and identification of rare actinobacteria from the marine sponge H. 
perlevis. The results showed that the different pretreatments and selective culture media 
employed to maximize the chances of recovering rare actinobacteria allowed the isolation 
of a large number of strains. These isolation techniques seem to be promising for the 
selection of rare actinobacteria, since the taxonomic identification of some isolates has 
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revealed the recovery of several actinobacteria genera considered rare. Though the 
results obtained are premature, these suggest that the marine sponge H. perlevis may be 
rich in actinobacteria. 
 
 Conclusion  
This thesis focuses on the isolation of actinobacteria from different sources of the 
Portuguese northern coast and on the study of their bioactive potential which, to our 
knowledge, has never been investigated before.  
The marine sediment collected from Parque Natural do Litoral Norte proved to have a high 
diversity of actinobacteria, with some of them showing a promising bioactive potential, and 
the results obtained point to the importance of bioprospecting other coastal marine 
sediments in Portugal. The high ability of actinobacteria to produce bioactive secondary 
metabolites, reported by numerous authors, was also observed in this study. 
The different pretreatments and selective culture media used to isolate rare actinobacteria 
from the sponge H. perlevis allowed the isolation of some rare actinobacterial genera, 
though the vast majority of the isolates has not yet been identified. The results so far 
obtained also suggest that the studied sponge seems to be rich in actinobacteria. 
As future work, it will be necessary to deeply investigate the bioactive potential of the most 
promising crude extracts and to analyze the presence of new bioactive substances. It will 
be also important to identify the remaining isolates recovered from the marine sponge H. 
perlevis and to screen the bioactive potential of their crude extracts. Overall, the results 
obtained in this thesis contribute to the increase of the scarce information available on 
culturable actinobacteria associated with marine sediments and sponges of northern 
Portuguese coast as well as on the bioactive potential of some of these isolates. 
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